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Abstract

Colonisation with Group B Streptococci (GBS) is a major risk factor for neonatal infection
acquired via vertical transmission during pregnancy, labour, or birth, potentially resulting in
significant morbidity and mortality. Universal screening at 35 – 37 weeks gestation for
maternal GBS colonisation and the use of intrapartum antibiotic prophylaxis has resulted in
substantial reductions in the burden of neonatal Early-Onset GBS Disease (EOGBSD).
Women in Western Australia (WA) are offered GBS screening in pregnancy and intrapartum
antibiotic prophylaxis. Anecdotal evidence suggests variations in viewpoints and thus low
adherence to relevant clinical guidelines amongst midwives and pregnant women in the
midwifery led model of care. To date, no research has been undertaken to provide empirical
evidence for these anecdotal reports, suggesting the need for research.
This study has aimed to investigate the adherence to recommended GBS screening
guidelines across five maternity hospitals in metropolitan and regional WA. Three objectives
guided this research conducted within two different cohorts (midwifery and non-midwifery
led) plus subgroups including Midwifery Group Practice (MGP), Community Midwifery
Program (CMP) and Private Midwives (PM): 1) determination of GBS colonisation rates; 2)
the examination of adherence to antenatal GBS screening; and 3) examination of adherence
to the intrapartum antibiotic prophylaxis protocol.
This retrospective WA study has employed a quantitative research design using
administrative health data that included 22,417 pregnant women who gave birth between
2015 – 2019. Descriptive statistics were applied using secondary data analysis to describe the
characteristics and patterns of GBS screening guideline adherence. The results were
compared between all involved study cohorts.
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The study revealed similar GBS colonisation rates amongst pregnant women in all
included study groups. A lower adherence to the GBS screening guidelines was found in the
midwifery led model of care when compared to the non-midwifery led model of care. Over
the five-year period, screening rates trended down in the midwifery led population whilst the
numbers remained stable in the non-midwifery led cohort. When the MGP groups were
compared across the five hospitals, vast variations were discovered. Further, when rates of
adherence were investigated in relation to intrapartum antibiotic prophylaxis, discrepant
findings emerged between the study groups.
This study not only fills an important gap in the existing literature, it also seeks to assist
guidance and improvement of clinical protocols in relation to GBS screening to reduce the
risk of neonatal infection. Recommendations include educational interventions and the need
for further research.
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Chapter 1 – Introduction

Group B Streptococcus (GBS), also known as streptococcus agalactiae, is a major cause
of morbidity and mortality in neonates globally (Seale et al., 2017). In Western Australia
(WA), the risk of GBS disease in pregnancy has primarily been managed through
recommendations of universal screening at 35 – 37 weeks gestation, with the administration
of prophylactic antibiotics in labour if the screening result returns positive for vaginal or
rectal GBS colonisation (Homer et al., 2014). However, knowledge is limited regarding the
comparison of adherence to GBS screening between pregnant women cared for under the
midwifery led model of care, and those cared for under the non-midwifery led model of
pregnancy care. Likewise, to date the comparison of screening results between these two
models has not been fully examined.1
This chapter commences with a brief background of the researcher’s interest in the
research topic, followed by an overview of the effects of Group B Streptococcus colonisation
in pregnancy on neonatal health. Then, it provides a description of the risk of Group B
Streptococcal disease in neonates and its management by antenatal care providers. Following
this foundational layout, the different models offered in pregnancy care are introduced. Then,
an outline of the problem, research aims, objectives and question are offered including an
explanation of the significance of the study. The chapter concludes with an overview of the
thesis structure.

1

These models will be explained on pages 7 -13
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The Researcher’s Background
The condition of GBS colonisation in pregnancy and its management have long been a
particular interest of mine. Whilst working as a clinical midwife in a tertiary hospital for over
a decade, I grew concerned about the large amount of antibiotics administered to women with
a positive GBS screening result whose labour was induced. At that time, women received
intravenous antibiotic prophylaxis from the start of their induction of labour (IOL), including
a mostly lengthy phase of cervical ripening (average 24 hours) prior to the artificial rupture of
membranes and commencement of oxytocin infusion to induce labour. As a response to my
observations, I initiated and completed quality improvement research activities related to
GBS and antibiotic use in labour. The results showed that the total antibiotic use for women
whose labour was induced, ranged from five to nine doses whilst research evidenced that two
doses given at least four hours prior to birth are efficient in preventing neonatal infection
(Shah & Padbury, 2014). These findings were recognised and endorsed by the Obstetrics and
Gynaecology Directorate Management Committee and resulted in a change of clinical
guidelines and practice at the hospital I was employed at, reducing the amount of antibiotics
given to women undergoing IOL.
These experiences in the clinical setting were an enlightenment and encouragement for
me as indication that evidence-based research can lead to clinical practice change, resulting in
improved outcomes for women and their newborns. I presented the GBS topic at a midwifery
conference and to colleagues, held inspiring conversations with midwives and medical
doctors, and gained more insight from contemporary international literature. These
experiences have prompted me to examine this topic in more depth, especially as I have
observed that not many women of the midwifery led model of care who birthed in the
hospital were screened for GBS colonisation during their pregnancy.
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Group B Streptococcus in Pregnancy and Neonatal GBS Infection
Group B Streptococcus is a fast-growing gram-positive bacterium which commonly
colonises the upper respiratory tract, as well as the gastrointestinal and genitourinary tract of
approximately 30% of asymptomatic adults (Murray et al., 2016). Ten different GBS
serotypes have been identified, where serotypes Ia, Ib, II, III, and V have become known as
the major causes of GBS disease (Vornhagen et al., 2017). During pregnancy, GBS can
increase the risk of urinary tract infection, chorioamnionitis, endometritis, and sepsis,
featuring as a risk factor for miscarriage, preterm labour and stillbirth (Steer et al., 2020).
Typically colonising a pregnant woman’s intestinal and/or genitourinary tract, GBS can
spread to the amniotic fluid, placenta, cervix, or vagina (Heath & Jardine, 2014). The fetus
can then acquire the bacteria either in-utero via vertical transmission, during labour (even
with membranes intact) or during vaginal birth (Steer et al., 2020). Invasive Early-Onset GBS
Disease (EOGBSD), which occurs from 0 – 7 days of life, can result from this, leading to
serious complications for neonates including meningitis, pneumonia, and neonatal sepsis,
where it continues to be a major cause of morbidity and mortality amongst term and preterm
neonates (HogenEsch et al., 2020). Neonates who survive a GBS infection can suffer from
long term effects and permanent problems, for example blindness, deafness, moderate to
severe neurological impairments, and cerebral palsy (WHO, 2017). Seale et al. (2017) have
reported a global disability rate of greater than 10,000 incidents “…of neurodevelopmental
impairment per year due to infant GBS meningitis” (p. 216).
A large retrospective analysis of data collected from multiple hospitals in Australia and
New Zealand has reported an EOGBSD rate of 0.43/1000 live births with a mortality rate of
11% (Singh et al., 2019). Preterm neonates are at significantly increased risk, amounting to
3% for infection rates and up to 30% of mortality rates (Heath & Jardine, 2014). The
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following section addresses preventative strategies aimed at reducing the risk of invasive
GBS infection in neonates.
Management of the Disease
Universal GBS screening has been an effective tool for tackling neonatal sepsis, where
it includes rectovaginal culture swabs between 35 and 37 weeks of gestation to identify
women who are colonised with GBS (Hasperhoven et al., 2020). These women are then
offered intravenous antibiotic prophylaxis during labour, or if membranes have ruptured,
before labour begins. This preventative strategy has led to a significant reduction in
EOGBSD and is considered more effective than a risk-based approach where intrapartum
antibiotics are administered on determination of certain risk factors for EOGBSD including,
prolonged rupture of membranes (≥18 hours), a previous neonate with EOGBSD, GBS
bacteriuria, or maternal fever (≥38ᵒC) (Hasperhoven et al., 2020).
Even though globally implemented strategies have been successful in reducing neonatal
GBS infection (Russell, Seale, O’Sullivan et al., 2017), the burden of the disease is high, with
invasive neonatal infection “accounting for more than the combined neonatal deaths from
tetanus, pertussis, and respiratory syncytial virus” (WHO, 2017, p. 1). Globally, an estimated
150,000 stillbirths and neonatal deaths each year are attributed to GBS infection (WHO,
2017).
Recent research has examined the development of a more efficient method for timely
detection of GBS, resulting in trialing rapid Polymerase Chain Reaction (PCR) test methods
internationally (Carrillo-Ávila et al., 2018; Church et al., 2017; Clouse et al., 2019; Fullston
et al., 2019; Koppes et al., 2017; Picchiassi et al., 2017; Tanaka et al., 2016; Wollheim et al.,
2017). These studies have concluded that GBS PCR tests produce highly accurate results in
up to 50 minutes, reduce the use of intrapartum antibiotics, and can detect low-count bacteria.
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Further, GBS PCR tests are not affected by the presence of amniotic fluid or blood, can limit
costs for the health care provider, and are not workload intensive (Picchiassi et al., 2017).
Another promising strategy for reducing the GBS disease burden is maternal
vaccination, which currently is in active development (Berardi et al., 2020; Giles et al., 2019;
Kobayashi et al., 2016). Seale et al. (2017) have estimated that a GBS vaccine with an
efficacy of 80% and 90% coverage could prevent 229,000 maternal and neonatal GBS
incidents, 41,000 stillbirths, and 67,000 neonatal deaths. In the 1980s, it was first established
that immunisation-induced maternal antibodies can cross the placenta and protect the neonate
from invasive GBS infection (Steer et al., 2020). Accordingly, an effective vaccine could
play a crucial role in reducing the risk of antibiotic resistance as it would supplement
intrapartum antibiotic prophylaxis (Carreras-Abad et al., 2019), with the potential to prevent
stillbirths, preterm births and neonatal late-onset GBS infection (Seale et al., 2017). Low and
middle-income countries, where access to health care can constitute a challenge and the
infrastructure of a health system is likely to be limited, would be amongst the major
beneficiaries of a maternal GBS vaccine (Kobayashi et al., 2016). Kristeva et al. (2017) have
reviewed international studies of GBS vaccine trials, finding that an investigational of
CRM197 trivalent vaccine that covers the three most common GBS serotypes, demonstrated
sufficient immunogenicity and an absence of serious adverse effects. However, the authors
also stressed the importance of further research concerning the development of a vaccine that
would be able to cover all ten GBS serotypes (Kristeva et al., 2017). Therefore, until a safe
maternal GBS vaccine becomes available, the application of antenatal GBS screening and the
use of intrapartum antibiotic prophylaxis remain the most effective tools for reducing earlyonset neonatal GBS infection (Steer et al., 2020).
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Impact of Non-Adherence to Antenatal GBS Screening
Compelling evidence demonstrates the negative impact of low uptake of GBS screening
on neonatal infection rates (Hasperhoven et al., 2020). For example, a large surveillance
study by Matsubara et al. (2017), including 581,488 infants in Japan, found that compliance
with antenatal GBS screening guidelines was one of the factors influencing the incidence of
EOGBSD. Berardi et al. (2017) have similarly demonstrated that non-compliance with
antenatal GBS screening can result in missing “…more than 50% of full-term women at risk
of transmitting GBS [to the neonate]” (p. 1742). Similarly, HogenEsch et al. (2020) have
found higher neonatal infection rates in countries with low adherence to antenatal GBS
screening. A recent meta-analysis of 17 international studies confirmed that antenatal GBS
screening is associated with a lower incidence of neonatal EOGBSD when compared to the
risk-based method (Hasperhoven et al., 2020). Consequently, low or non-adherence to
antenatal GBS screening likely results in hospitals using a risk-based approach to prevent
neonatal infection. In this regard, it is important to note that in the United Kingdom (UK)
where the risk-based method has been adopted and where antibiotic prophylaxis is offered to
women with prolonged rupture of membranes, maternal fever during labour, GBS bacteriuria
during pregnancy, a history of a previous neonate with EOGBSD, has experienced an
increase in neonatal EOGBSD rates in the last two decades (Gopal Rao, Townsend et al.,
2017).
Importantly, a significant percentage of EOGBSD occurs in neonates with mothers not
demonstrating any of the risk factors (Eastwood et al., 2015; Gopal Rao, Townsend et al.,
2017; Hasperhoven et al., 2020), indicating that a large number of neonatal infections might
not be prevented using the risked-based approach. The following section provides an
overview of the various models of pregnancy care with an emphasis on the difference
between midwifery led care and non-midwifery led care.
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Models offered in Pregnancy Care (midwifery led vs non-midwifery led)
In 1998, the World Health Organization (WHO) presented principles of safe pregnancy
care. These principles include promoting normal birth with minimal interventions;
appropriate use of technology; maternity care based on evidence; local care (meaning within
a close range of the woman’s home) and efficient referral processes if needed;
multidisciplinary care; holistic, woman centred and culturally sensitive care; and informed
decision making (WHO, 1998). The Australian National Clinical Practice Guidelines adopted
and advanced on these principles with an aim to offer women high quality care during
pregnancy and childbirth, as facilitated by health professionals including midwives, general
practitioners, obstetricians, and a range of allied health workers in primary and hospital
settings (WA Department of Health, 2019). These guidelines emphasise the importance of
maternity service accessibility to all women in Australia, focusing on optimising pregnancy
care experience particularly for Aboriginal and Torres Strait Islander women, adolescent
women, women with mental health disorders, refugee and migrant women, and women living
in remote and rural settings (WA Department of Health, 2019).
Over the last decade, significant advances have been made in the provision of maternity
care with the evolution of specific care models in Australia (Homer, 2016). Various models
of maternity care are available for Western Australian women, including public hospital care,
care from a general practitioner, private midwife or private obstetrician care, shared care, and
midwife care (WA Department of Health, 2019). In this study, maternity care facilitated by
midwives as primary caregivers is referred to as the ‘midwifery led model of care’ while all
other care options are referred to as ‘non midwifery led model of care’.
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The Midwifery Led Model of Care
The literature is not consistent in the way this model is classified, sometimes referring
to it as the ‘midwife led continuity model’ or ‘caseload midwifery’ (Sandall et al., 2016). In
this model of care, the midwife is the primary caregiver taking on the lead role as maternity
care professional responsible for planning and managing all steps from the antenatal booking
visit through to postnatal care (Sandall et al., 2016). This involves providing multiple services
to pregnant women including antenatal education, health promotion, counselling,
assessments, screenings, and especially promoting pregnancy and childbirth as normal
processes (Renfrew et al., 2014). If complications arise at any stage during the continuum of
the pregnancy, the midwife’s role is to identify the risks and to refer to the appropriate
specialist care (Sandall et al., 2016).
In general, women in the midwifery led model of care have uncomplicated pregnancies
and receive maternity care either in the community context, at Family Birth Centres or in a
hospital setting (Sandall et al., 2016). In recent years, this concept was extended to also
benefit women with medium to high risk factors (Lewis, Hauck, Crichton et al., 2016).
To ensure safe practices and professional conduct, the midwifery led model of care is
governed and reviewed by the professional standards and codes of the Nursing and
Midwifery Board of Australia and the International Confederation of Midwives (Nursing and
Midwifery Board, 2020). Additionally, the Australian College of Midwives has designed
policies and guidelines that are tailored to ensure best practice within specific types of
midwifery led care models and they include:
1.

The Australian College of Midwives Birth at Home Practice Standards (2016)

2.

The Australian College of Midwives Transfer from Birth at Home Guidelines
(2016)
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3.

Scope of Practice for Midwives in Australia (2016)

4.

Implementing visiting access for Medicare Eligible Midwives (Revised Edition
2015)

5.

National Midwifery Guidelines for Consultation and Referral – 3rd Edition, Issue 2
(2014)

6.

Social Media for Midwives and Midwifery Students (2014).

Further, midwives involved in home births are required to gain and maintain specific
skills and competencies in the following areas: perineal suturing; intravenous cannulation;
water birth; and obstetric emergencies (WA Department of Health, 2020b). Home births are
considered safe for women without any medical risk factors and are in growing demand for
women who want to birth in their own home environment with their family by their side
(Homer, Leap et al., 2019).
Continuity of Care and Minimal Medical Intervention. Continuity of care is a
central tenet of midwifery led care and promotes partnership between a known midwife and a
woman and her family during and after pregnancy (Homer, 2016). The care aims at limiting
conflicting advice to women – which is usually caused by the involvement of various
different care providers – and the provision of the same care philosophy from commencement
to the completion of care (Homer, Leap et al., 2019). Women have disclosed that knowing
their midwife has played a pivotal role in their perception of quality care (Lewis, Hauck,
Ronchi et al., 2016).
Women-Centred Care. Another reason why women tend to choose this care model is
its provision of holistic women-centred care tailored to the individual needs of women and
their families, resulting in informed decision making (De Masi et al., 2017). Fontein-Kuipers
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et al. (2018) have defined women-centred care as prioritising “…the woman’s individual
unique needs, as defined by the woman herself – assigning to the woman choice, control and
continuity of care” (p. 1). Midwifery led models of care are greatly suited for the womencentred approach because of the ability to providing care continuity and protecting normality
of labour and birth (Hunter et al., 2017).
Cost-Effectiveness. Several studies have explored the potential cost-effectiveness of
the midwifery led model of care for organisations (Attanasio et al., 2020; DonnellanFernandez et al., 2018; Hitzert et al., 2017; Ryan et al., 2013; Sandall et al., 2016; Schroeder
et al., 2012; Tracy et al., 2013). In a cohort of low-risk women, Attanasio et al. (2020)
compared cost estimates of childbirth in the midwife led and the obstetrician led model of
care and found that an average of $2,262 could be saved when women received midwifery
led care. A literature review evaluating the cost effectiveness of continuity of midwifery care
by Donnellan-Fernandez et al. (2018) has focused on studies by calculated expenses of
midwifery led care for women with high risk pregnancies. The review revealed limited robust
research, identifying only one article that stated risk stratification clearly and reported
findings of cost savings of $29 per pregnancy. Other research studies have either provided a
narrative report on cost savings only or did not formulate a clear statement on the pregnancy
risk level in the midwifery led care model and concluded that further research is needed to
assess cost effectiveness in this context.
Types of Midwifery led Models of Care. Western Australian women can access
midwifery led models of care by referral from their general practitioner or by using the selfreferral option on online webpages or via telephone (Health Policy and Clinical Reform,
2007). Various models are available and are explained under the following headings:
Midwifery Group Practice (MGP). MGP is a small group consisting of four to six
midwives who meet the woman and provide continuity of pregnancy, intrapartum and
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postnatal care, ensuring that two known midwives attend the birth (Bradfield, Hauck, Kelly et
al., 2019) . This model of midwifery led care was implemented across Australia in the 1990s,
where today an average of 8% of pregnant women are provided care by MGP groups
throughout Australia (Hewitt et al., 2019). In metropolitan and regional WA, MGP groups
have been established at various participating hospitals and at the state’s only Family Birth
Centre (WA Department of Health, n.d. a). Traditionally, this model of care has been suitable
for pregnant women in the low risk category but has been redesigned during the last decade
to also benefit women with medium to high pregnancy risks (Lewis, Hauck, Crichton et al.,
2016).
Community Midwifery Program (CMP). The CMP “…is a publicly funded midwifery
led service that provides continuity of care from a known midwife from 16 weeks of
pregnancy, throughout labour, birth and for up to two weeks post birth” (Bradfield, Hauck,
Kelly et al., 2019, p. 2). Eligible pregnant women who live in a specified catchment area can
choose to birth at home, at a participating hospital, or at the Family Birth Centre whilst
receiving care from a known community midwife (WA Department of Health, n.d. b).
Within the MGP and CMP models, an average of five midwives form a group to
provide continuity of care whilst ensuring availability of back up when necessary by a
midwife known to the woman (Tracy et al., 2013). It has been estimated that midwives in the
midwifery led model of care who work in a team setting can provide care for an average of
40 women annually whilst backing up team colleagues in 40 additional cases (Tracy et al.,
2013).
Private Practice Midwifery. Women who choose this privately funded model, receive
all aspects of pregnancy care through a self-employed independently working midwife. These
women mostly opt for birth at home, or sometimes in public hospitals where admission rights
are granted (Bradfield, Hauck, Kelly et al., 2019). Upon mutual agreement, women meet with
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their private midwife at home or at the midwife’s business facility (Davison, 2019). At the
time of this study, there were ten independently working midwives in metropolitan WA, of
which some have Medicare eligibility and birthing rights at the tertiary maternity hospital.
The Non-midwifery Led Model of Care
There are various maternity care provider models other than the midwifery led model of
care, which were all grouped into the non-midwifery led model of care. In this model,
medical doctors including general practitioners and private or hospital obstetricians provide
the primary care for the pregnant woman. Most of the time this means that the medical doctor
whom the woman receives antenatal care from, will not be present at birth, where midwives
provide intrapartum and postnatal care but do not carry a leading or decision making role. In
these cases, this is the remit of a hospital doctor, who either attends the birth or is on call
(Sandall et al., 2016). This model of conventional pregnancy care is sometimes criticised
because of its lack of continuity of care and changing staff during care, where care givers can
include various clinicians such as midwives, midwifery students, obstetricians, junior medical
doctors, and medical students (Brock et al., 2014).
In private obstetric care, the obstetrician is the woman’s lead maternity care provider
and attends to her pregnancy needs and facilitates the birth, whilst a midwife or obstetric
nurse provides care throughout labour and the postnatal period under the obstetrician’s
supervision. Specific types of shared care fall into the same non-midwifery led model of care,
where responsibilities are shared between various organisations and health professionals. For
example, a woman that receives antenatal care in a rural hospital or from her local health
practitioner is required to attend an obstetric expert or specialist facility intermittently
throughout the pregnancy and/or for care in labour due to her medium or high risk pregnancy
(Health Policy and Clinical Reform, 2007).
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The Problem
Universal GBS screening in pregnancy and intravenous antibiotic prophylaxis in labour
for women with a positive GBS test result can reduce the risk of invasive GBS infection in
neonates. Whilst this preventative strategy is recommended in WA (Homer et al., 2014), no
evidence was available demonstrating the adherence to these clinical guidelines amongst
pregnant women, neither in the midwifery led model of care nor in the non-midwifery led
model of care.

Significance of the Study
While there has been international research regarding adherence to antenatal GBS
screening guidelines (Dalmartello et al., 2019; De Luca et al., 2016; Gopal-Rao, Nartey et al.,
2017; HogenEsch et al., 2020; Kunze et al., 2015; MacLaughlin et al., 2014; Silva et al.,
2013; Yamaguchi & Ohashi, 2018), as well as two Australian studies (Braye et al., 2019;
Moorhead et al., 2019), only one has been identified with a focus on adherence to GBS
screening guidelines specifically within the midwifery led model of care (Yamaguchi &
Ohashi, 2018). Further, no Western Australian research on this particular topic was found.
This study makes a significant contribution to the contemporary knowledge about adherence
to antenatal GBS screening guidelines within two different target groups of pregnant women
in WA, the midwifery led model of care and the non-midwifery led model of care. It is
expected that the findings of this research project will extend beyond the Western Australian
context and provide assistance in building evidence that informs policy, planning and the
delivery of clinical care to reduce the risk of early-onset neonatal Group B Streptococcal
infections. Consequently, it is anticipated that the findings of this study will contribute to
improved health outcomes for both mothers and babies.
Additionally, in relation to further research, the results have significance because they
provide vital baseline statistics that might be used as a basis for replication studies and
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qualitative investigations exploring reasons for adherence in more depth and trialling new
methods for improved management of GBS disease in pregnancy.

Research Aim and Objectives
The overall aim of this study has been to investigate the adherence to the recommended
prevention strategy for early-onset neonatal GBS infection in WA in pregnant women of the
midwifery led and the non-midwifery led model of care who gave birth between 1 January
2015 and 31 December 2019.
The following objectives guided this study:
1.

To determine the overall and population specific rate of GBS colonisation in
pregnancy in all groups under study

2.

To examine the prevalence of antenatal GBS screening adherence specific to the
midwifery led model of care group, the non-midwifery led model of care group and
subgroups including Midwifery Group Practice, the Community Midwifery
Program, and the group of Private Midwives using electronic administrative birth
data

3.

To examine the adherence to intrapartum antibiotic prophylaxis in all groups under
study when antenatal GBS screening showed a GBS positive result

Research Question
What is the prevalence of adherence to the GBS screening protocol amongst pregnant
women of the midwifery led model of care and the non-midwifery led model of care in a
multi-centre study setting in WA?
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Design
The proposed research question is most suitably answered using quantitative
methodology due to the nature of the objectives as well as the data sources comprising a large
amount of electronic administrative health data. Descriptive statistics will be presented to
systematically examine and identify the overall and specific adherence to GBS screening in
the two different models of care.

Thesis Structure
This thesis consists of six chapters, beginning with this introduction chapter that
outlines the researcher’s personal background and interest in the research topic. This is
followed by an overview of the significance and management of GBS disease in pregnancy
and a discussion of the midwifery led versus the non-midwifery led model of care. A problem
statement and an explanation of the significance of the study are provided, leading to the
presentation of the research aims, objectives and research question and concluding with
comments on the design.
Chapter 2: Literature Review – This chapter provides an overview of findings and
outcomes of international peer reviewed studies related to adherence to antenatal GBS
screening guidelines examining this topic from different angles. Given the scarcity of
research on this topic in midwifery led care models, the search was broadened to literature
including any maternity care provider.
Chapter 3: Methodology – This chapter showcases the steps of how the research was
conducted and includes philosophical and theoretical foundations, a description of the
quantitative research design, an explanation of the process of secondary data collection, data
source and analysis, as well as the ethical considerations of the study.
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Chapter 4: Results – This chapter provides the results of the study.
Chapter 5: Discussion – This chapter presents an interpretation of the results and
discusses the findings against the background of the academic literature. It also provides an
explanation of the strengths and limitations of the study.
Chapter 6: Conclusion and Recommendations – This chapter summarises the research
project and findings, along with presenting concluding remarks and making
recommendations for future directions for clinical practice and further research.

Summary
This chapter commenced with an illustration of the researcher’s background,
emphasising her interest in the research topic of GBS in pregnancy, its management and
prevention of neonatal infection within the midwifery led and the non-midwifery led model
of care. Then, the background to the problem was outlined, including a description of the
impact of GBS colonisation in pregnancy on neonatal infection, prevention strategies and
effects of non-adherence to GBS screening guidelines. This was followed by introducing the
different models offered in pregnancy care. The paucity of research in relation to GBS
screening guideline adherence, particularly in the midwifery led model of care context, was
the key motivator in this study. Further in this chapter, a problem statement and an
explanation of the study’s significance were offered, leading to a statement of research aim,
objectives and question and commenting on the study design. Finally, an overview of the
thesis briefly explained the contents of each chapter. Chapter 2 provides a detailed review of
the literature in the context of adherence to antenatal GBS screening guidelines.
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Chapter 2 – Literature Review

This chapter provides an in-depth literature review relating to the adherence to
antenatal Group B Streptococcus (GBS) screening guidelines. The reviewed literature focuses
on adherence to these guidelines in both midwifery led and non-midwifery led models of
care, in a variety of global maternity care settings. A narrative approach was used, with a
purpose towards collating information on contemporary knowledge of adherence to GBS
screening guidelines, including current applications within clinical practices. The review has
been structured according to Ferrari’s (2015) Introduction, Methods, Results, and Discussion
(IMRaD) format, including an introduction, a description of the methods, a presentation of
the results and a discussion section. Whilst various key themes and subthemes emerged, this
literature review has revealed a scarcity of studies in the context of the midwifery led model
of care, where this research aims to address this gap of knowledge. The chapter concludes
with a summary of the main points, followed by an outline of the next chapter.

Introduction
The purpose of this literature review was to examine the current body of available
knowledge on GBS screening in pregnancy and management of GBS colonised women. The
review critically appraised international literature relating to the adherence to antenatal GBS
screening guidelines in the midwifery led and the non-midwifery led models of care. The
review provided a synthesis of what is known about current adherence to antenatal GBS
screening protocols in a variety of global settings, including birthing centers, private obstetric
practice, and hospital clinical environments. Some of the literature applied the term
‘maternity home ’, where midwifery led care is provided. A systematic search of published
articles was conducted, leading to a textual narrative synthesis (Ferrari, 2015). This synthesis
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discussed three themes identified in the literature, namely 1) universal GBS screening; 2)
controversy approaches; and 3) Intrapartum Antibiotic Prophylaxis (IAP). The review further
identified gaps in the literature. The review commences by describing the literature search
methods, then it presents a summary of findings, which is followed by a discussion of
identified themes.

The Literature Search Methods
The search strategy was guided by principles outlined by Ferrari (2015) and Siddaway
et al. (2019), involving searches of electronic databases and reference lists of identified
articles to locate potentially relevant studies. Keywords and specific vocabulary terms that
guided the search included: Group B Streptococcus screening, universal GBS screening,
Group B Streptococcus, GBS colonisation, pregnant women, midwifery group practice,
community midwives, private midwives, midwifery led care, risk-based approach, and
adherence/compliance to GBS screening guidelines.
Inclusion and Exclusion Criteria
International journal articles published between 2013 – 2020 were included in the
review regardless of methodology used, in order to reduce the risk of overlooking
publications (Aromataris & Pearson, 2014). Only peer reviewed primary research studies that
reported on adherence/compliance with antenatal GBS screening guidelines were selected.
Articles were excluded if there was no report on ethical approval, were abstracts only, if the
written language was other than English, or if the article was an editorial.
The literature search yielded three key themes relating to the research question of this
study. Several sub themes emerged and are discussed under these major themes. It is
important to note here that although these sub themes are distinctive concepts, there are
shared overlapping characteristics in relation to adherence to antenatal GBS screening
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guidelines. The term ‘adherence’ is used throughout the thesis in relation to antenatal GBS
screening that fits within midwifery philosophy. However, in this literature review the term
‘compliance’ was applied when it was used in the reviewed studies.

The Universal GBS Screening Approach
GBS Colonisation
In healthy women, asymptomatic colonisation with GBS is common and normally not
harmful. However, in pregnancy GBS can be the cause of infections including “…bacteriuria,
amnionitis, fasciitis, cellulitis, endometritis and wound infections associated with
episiotomies or caesarean deliveries” (Shabayek & Spellerberg, 2018, p. 2). The colonisation
in the vagina and/or rectum of a pregnant woman is recognised as the most significant reason
for invasive neonatal infections, in particular Early Onset Group B Streptococcal Disease
(EOGBSD) (Haiko et al., 2018). A background for these implications was presented in the
introduction chapter of this thesis. Notably, the risk of GBS transmission from the woman to
the neonate is significantly higher with a greater density of GBS colonisation (>100 colonies
in 10µl compared to a density of <50 GBS colonies in 10 µl) (Kunze et al., 2015).
Since GBS was first recognised as the major cause for morbidity and mortality in
neonates in the 1970s (Shabayek & Spellerberg, 2018), many international studies have
examined the prevalence of maternal colonisation with GBS. For example, Russell, Seale,
O’Driscoll et al. (2017) estimated that 18% of women are colonised with GBS in pregnancy
on a global scale. The rates vary regionally, from 11% to 35%, while low prevalence of GBS
was observed among pregnant women of Southern and Eastern Asian countries (12.5% and
11% respectively). The authors reported similar rates for North America, Europe and
Australia, ranging from 15% – 21%. In WA, only one study was available that examined the
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overall maternal colonisation with GBS, which was found to have a rate of 24% (Furfaro et
al., 2019).
Screening for GBS in Pregnancy
Following the recognition of GBS presenting as the principal cause for EOGBSD
(Simonsen et al., 2014), it seemed an urgent step to find and introduce a screening method for
the detection of GBS colonisation in a pregnant woman. In order to decrease the risks of
vertical transmission to the neonate, “…early detection of [colonised women] allows timely
intervention” and is crucial in preventing neonatal infection (Dalmartello et al., 2019, p.
2049). In 2002, at the Centers for Disease Control and Prevention (CDC) in the United States
of America (USA), a strategy evolved to recommend universal GBS screening in pregnancy
as a result of many studies (Steer et al., 2020).
The screening procedure is simple and involves obtaining a recto-vaginal swab between
35 and 37 weeks gestation, which is then cultured in a laboratory for the isolation of GBS
(Steer et al., 2020). Techniques for GBS screening by culture are time-consuming and take 24
– 72 hours to produce a result (Koppes et al., 2017). This preventative strategy has led to a
significant reduction of EOGBSD in neonates (Moorhead et al., 2019). In the 1970s, a
neonatal case fatality rate of 50% was reported in the USA due to EOGBSD; however, a
major decline of infection rates (0.23/1000 live births) in 2015 was achieved following the
implementation of universal GBS screening and intrapartum antibiotic prophylaxis (Filkins et
al., 2020). Another advantage of this strategy is that it facilitates more time to be taken
counselling the woman who is GBS colonised as well as testing antibiotic sensitivity in cases
of penicillin allergy (Steer et al., 2020). Prophylactic intrapartum antibiotic use will be
discussed in a later section.
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Limitations of the Universal Screening Approach
Some limitations of this strategy have been reported. For example, Tanaka et al. (2016)
have stated that the results of the screening test do not always reflect the GBS status at the
onset of labour because of the transient colonisation characteristics of GBS. This can lead to
women having unnecessary intrapartum antibiotics (Azad et al., 2016). If tested as GBS
positive in pregnancy, the GBS status may have changed to negative by the onset of labour.
Confirming this, a European study by Plainvert et al. (2017) reported that up to 40.7% of
pregnant women who tested GBS positive via culture screening between 35 – 37 weeks
gestation, tested GBS negative at birth, whereas 21% of women with a negative antenatal
screening result were tested positive for GBS at the time of birth. In contrast, women may
forego crucial antibiotic prophylaxis if their GBS status in labour has changed to positive
from an antenatal negative screening result (Khalil et al., 2019). Matsubara et al. (2017) have
previously revealed similar findings, noting 75% of neonates with EOGBSD to have mothers
who were not colonised with GBS at their antenatal screening test. Further, the techniques of
GBS screening by culture are time-consuming, whereby they are sometimes not available for
women in preterm labour (Koppes et al., 2017).
Antenatal Screening and Elective Caesarean Section
According to revised Centers for Disease Control and Prevention Guidelines, all
women, including those who birth via an elective caesarean section, are recommended to
undergo antenatal GBS screening (CDC, 2020b). Nonetheless, Silva et al. (2013) have
observed that for those in private obstetric practice especially, adherence to these guidelines
was low, particularly for planned caesarean sections. When screening rates in cases of
vaginal births were analysed separately to caesarean section births, vast differences were
found (Silva et al., 2013). The authors argued that antenatal GBS screening guidelines are not
universally promoted by obstetricians in private practice. With an average 43% caesarean
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section rate that amounts to 80% in private obstetric practice, Brazil is considered one of the
countries with the highest rates in the global context (Silva et al., 2013). This high proportion
of caesarean sections was suggested to be a possible reason for low GBS screening
compliance, as the risk of GBS transmission to the neonate is considered low with elective
caesarean section births (Silva et al., 2013). However, Albright et al. (2017) have
recommended GBS screening when the mode of birth is a scheduled caesarean section for
several reasons, including the possibility of spontaneous labour prior to a planned caesarean
section, or the likelihood of prelabour rupture of membranes; both are risk factors for
neonatal GBS infection if the woman is colonised with GBS. The findings of a large
surveillance study has supported the need for universal GBS screening for women with
elective caesarean section births, showing that 13/1,277 GBS infected neonates were born via
caesarean section before labour commenced and membranes ruptured (Nanduri et al., 2019).
International Rates of Adherence to GBS Screening Guidelines
In many countries around the world the universal GBS screening approach and the
administration of intrapartum antibiotics have been incorporated into clinical guidelines as a
recommendation to prevent neonatal EOGBSD (Rao & Khanna, 2020). Findings from a
systematic review report that 35 countries have implemented this approach within their
clinical practice (Le Doare et al., 2017). Few specific studies have been identified that
investigate and report on the adherence to the GBS screening in pregnancy.
One study from the USA, a country with high awareness of the risks of neonatal GBS
infection amongst maternity care providers, has demonstrated a high adherence rate to
antenatal screening guidelines, with 96.8% compliance among family medicine providers
(MacLaughlin et al., 2014). In contrast, Yamaguchi and Ohashi (2018) have investigated
rates of compliance with GBS screening guidelines amongst birth centre midwives in Japan.
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Their 204 completed questionnaires (response rate 60.5%) showed that only 47.5% of birth
centres adhered to the recommended guidelines. Similarly, Silva et al. (2013) who used a
randomised controlled clinical trial in a study of 241 private obstetricians in Brazil, showed
low overall GBS screening rates, ranging from 15.9 % before implementation of educational
interventions to 25.4% afterwards.
In Europe, various countries have adopted the universal screening approach for the
detection of GBS in pregnancy. For example, a German surveillance study by Kunze et al.
(2015) including 937 pregnant women revealed a low compliance rate of 67.5%. The authors
reported a poor adherence of 22.7% to the screening protocol, which involved screening
between 35 and 37 weeks gestation in addition to collecting combined recto-vaginal swabs
and specific processing procedures of the specimen. This was especially observed in private
practice. Further, a retrospective study of 7,133 pregnancies in an Italian region showed a
high rate of 93.2% compliance with antenatal GBS screening (Berardi et al., 2017). The
authors of this study highlighted an increase in compliance rates when compared with
findings from 2005 when they were reported to be 86.6%. In contrast, an earlier study by De
Luca et al. (2016) conducted research on the grounds of conflicting and limited data in Italy
in regard to health professionals’ attitudes relating to adherence to universal GBS screening
as per the recommendation of their national pregnancy guidelines. Findings of this study
demonstrated a low screening rate of only 67.9% amidst a relatively high colonisation rate of
30.2%, which corresponded with their opinion that not all practitioners promoted or
performed the GBS screening test. When the authors investigated the quality of the execution
of the screening test, they found that only 51.5% were performed properly as recto-vaginal
GBS swabs (De Luca et al., 2016).
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National Rates of Adherence to GBS Screening Guidelines
Australia does not provide a national guideline for GBS management in pregnancy,
resulting in every state implementing different approaches. A review of Australian national
guidelines shows that some states have no specific protocol, one state uses the risk-based
approach (this approach will be explained in the controversy section), and other states apply
either approach (Homer et al., 2014). Further, limited data were found in the context of
adherence to prevention strategies nationally. One Australian retrospective cohort study of
62,281 pregnant women investigated compliance with GBS screening following a transition
from the risk-based to the universal GBS screening approach in a local health district, causing
a dramatic reduction in neonatal EOGBSD (Braye et al., 2019). A total screening rate of 76%
was reported in varied birthing facilities such as a tertiary hospital, birth centres as well as
regional and rural units.
Another Australian study has emphasised the importance of the antenatal universal
screening strategy (Moorhead et al., 2019). With a focus on interventions to improve rates of
screening, the researchers performed a retrospective investigation of 741 pregnancy records
and reported a stable compliance rate with GBS protocols of 84.4% prior, during and after
updating and promoting EOGBSD prevention guidelines.
Regional Rates of Adherence to GBS Screening Guidelines
In WA, the recommended strategy to prevent early-onset neonatal GBS infection is
universal GBS screening in pregnancy at 35 – 37 weeks gestation in combination with
intravenous antibiotic prophylaxis in labour for women with a GBS positive test result
(Homer et al., 2014). However, no information is available on the adherence to these
recommendations. Consequently, further research is needed to fill this gap.
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In summary, GBS remains a major cause for neonatal infection. Colonisation rates were
found to vary regionally, up to 35% in a global context. Antenatal universal screening has
been proven to be an effective method to detect GBS colonisation in pregnant women, where
multiple countries have adopted this screening approach. However, international studies
demonstrate greatly varying antenatal GBS screening adherence rates, ranging from 15.9% in
Brazil to 96.8% in the USA. In Australia, no national guidelines have been offered, resulting
in different approaches being implemented across states and territories.

The Controversy
Even though universal GBS screening in pregnancy is thought to be more effective than
the risk-based approach in targeting intrapartum antibiotic prophylaxis for the prevention of
EOGBSD (Steer et al., 2020), an ongoing debate exists between the two approaches
(antenatal screening vs. risk-based approach). The following section provides a description of
the risk-based approach.
The Risk-Based Approach
In contrast to the antenatal screening approach, the risk-based approach falls into the
expectant management category as pregnant women do not get tested for GBS colonisation
but are observed for specific risk factors (Rao & Khanna, 2020). These include GBS
bacteriuria, prolonged rupture of membranes (>18 hours), previous GBS infected neonate,
maternal fever, and preterm labour (<37 weeks gestation) (Steer et al., 2020). A systematic
review by Le Doare et al. (2017) has reported that globally 14 countries have adopted this
approach, where some local health care providers in 11 other countries use this strategy as
well. Of note, both in the UK and the Netherlands, who follow the risk-based approach, a
recent increase in neonatal EOGBSD has been reported (Hasperhoven et al., 2020). It is
possible that the rationale for this choice of strategy by maternity care providers relates to
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beliefs around adding to the medicalisation of labour and birth and saving costs (Di Renzo et
al., 2015). Further, a recent UK study using modelling techniques has demonstrated that to
prevent one incident of EOGBSD, 1,675 to 1,854 additional women require administration of
antibiotic prophylaxis, where 24,065 to 32,087 would require administration for avoiding one
neonatal fatality due to EOGBSD, if the antenatal GBS screening approach would be used
(Bevan et al., 2019). This reflects concerns of overusing antibiotics, which will be discussed
in the following section.
In recent years, various maternity care providers have considered changing to the
antenatal GBS screening approach (Björklund et al., 2017). For example, Gopal-Rao, Nartey
et al. (2017) in a study of a population of 9,098 pregnant women in a North West London
hospital with a high incidence of GBS disease found that rates of neonatal EOGBSD were
reported to be nearly four times as high as the national rate, despite adherence to the riskbased approach to prevent neonatal infection. This led to a collaborative decision to introduce
and offer women the antenatal GBS screening routinely and prophylactic antibiotic use in
labour for women with a GBS positive result. A significant outcome followed, with the
reduction of neonatal EOGBSD from 0.99/1000 births prior antenatal screening to 0.33/1000
births after GBS screening was introduced. While the study revealed a five times higher
EOGBSD rate in neonates whose mothers were not screened compared to the screened
population, it reported that 1,459 women needed GBS screening to obviate one incident of
invasive neonatal EOGBS infection (Gopal-Rao et al., 2017).
Some studies within the literature have criticised the risk-based approach. For example,
a large retrospective observational study by Eastwood et al. (2015) conducted in Northern
Ireland, found that 44.2% of women with infected neonates had no risk factors present.
Similarly, a recent meta-analysis by Hasperhoven et al. (2020) reported that 41.3% of infants
with invasive EOGBSD were born to mothers with no presenting risk factors. Further, a
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report by the British Paediatric Surveillance Unit surveying EOGBSD in neonates born
between 2014 – 2015, demonstrated that in 64% of neonatal GBS infections no maternal risk
factors were identified (Gopal Rao et al., 2017a).
Overuse of Antibiotics
Another reason for some maternity care providers using the risk-based approach is the
growing concern about the possible overuse of antibiotics leading to antibiotic resistance and
interference with the neonatal microbiome (Rao & Khanna, 2020). In this context, Braye et
al. (2019) have presented a sceptical view in addressing limitations of the antenatal GBS
screening approach, noting possible exposure to unnecessary antibiotic administration as
having interrupting effects on the neonatal microbiome. The authors identified that the
number of pregnant women and neonates receiving antibiotic prophylaxis had increased
twofold (from 12% to 30%) locally. Based on the study’s findings of no change in neonatal
EOGBSD observed in the screened and unscreened group over time, Braye et al. (2019)
recommended the risk based approach along with appropriate antibiotic prophylaxis to reduce
the risk of GBS infections in neonates. Similarly, following a systematic review, Seedat et al.
(2019) have concluded it to be safer to follow the risk-based approach because of the
unknown potential adverse effects of antenatal GBS screening and widespread intrapartum
antibiotic prophylaxis on neonates despite the lack of evidence in this study. Another study
assessing 84 neonates’ gut microbiota reported that neonates of women who received
antibiotics in labour had a much lower count of Bifidobacteria, which is important for the
immune system, compared with neonates of the control group (Corvaglia et al., 2016).
However, the authors reported that at 30 days of age, these neonates demonstrated no
detectable differences in the count of the Bifidobacteria. Similar results have been discovered
by Metz et al. (2020) who examined whether GBS antibiotic prophylaxis had an impact on
Body Mass Index (BMI) in young children. The study showed corresponding body mass
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indexes between exposed and unexposed children and pointed out that previous studies with
different findings did not take the reason for antibiotic administration nor the child’s
“…resultant inflammatory milieu” into account (Metz et al., 2020, p. 3322).
Seedat et al. (2017) have drawn conclusions from their systematic review stating
limited evidence that administration of intrapartum antibiotic prophylaxis for the prevention
of neonatal GBS infection is the cause for severe adverse outcomes for neonates due to the
lack of unbiased good quality studies (Seedat et al., 2017). In agreement, Hasperhoven et al.
(2020) did not share concerns of overuse of antibiotics in labour, suggesting that the number
of women receiving them corresponded in both groups, the screening and the risk-based
population, in their systematic review. However, the authors commented on the possibility of
bias deriving their evidence “…from observational data in an inherently heterogeneous set of
studies” (p. 9).
Braye et al. (2019) have stated that prophylactic antibiotic use in labour is more
frequently applied in the antenatal GBS screening approach population as compared to the
risk-based approach, where rising concerns about antibiotic resistance are grounded in good
evidence. Antibiotic resistance is now acknowledged as a global crisis jeopardising the
excellent health outcomes gained from antibiotic use (Laws et al., 2019). The World Health
Organization (WHO, 2020) has defined antibiotic resistance as a serious event where
“…bacteria, viruses, fungi and parasites change over time and no longer respond to
medicines making infections harder to treat and increasing the risk of disease spread, severe
illness and death” (para. 3). The overuse and misuse of antibiotics are key factors in the
emergence of antibiotic resistance (WHO, 2020). Various bacteria have developed resistance
over many years of antibiotic use including Staphylococcus, Escherichia coli, Enterococcus,
Candida auris, Neisseria gonorrhoeae to name a few (CDC, 2020a). Group B Streptococcus,
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the source of the problem studied in this research, remains susceptible to penicillin, the first
line of intrapartum antibiotics whilst susceptibility is declining with alternatively used
antibiotics including clindamycin and erythromycin (Hayes et al., 2020).
In this section, the risk-based approach was described as an alternative approach for
preventing neonatal EOGBSD. An ongoing debate between the two preventative approaches
was discussed including concerns for overusing intrapartum antibiotics. Limited evidence is
available in relation to interference with the neonatal microbiota, whereas antibiotic
resistance was shown to be a major challenge. The outcomes of studies tended to favour the
screening approach as opposed to the risk-based approach in showing reduction in neonatal
EOGBSD.

Intrapartum Antibiotic Prophylaxis (IAP)
Characteristics of Antibiotics
The administration of IAP plays a crucial role in preventing neonatal EOGBSD and is
indicated when a mother tests positive for GBS colonisation and/or any risk factors are
present (CDC, 2020b). As described by Puopolo et al. (2019), there are three ways
intrapartum antibiotics prevent EOGBSD: by 1) reducing GBS colonisation in the vagina
temporarily, 2) obviating GBS colonisation on fetal or neonatal skin and mucus membranes
and 3) achieving an effective level of the antibiotic in the neonate’s blood for biocidal action.
The preferred type of antibiotic is penicillin due to “… its narrower spectrum of antimicrobial
activity, its resultant decreased potential for selection of resistant organisms and its likely
minor effect on enteric bacterial species” (Melin, 2011, p. 1299). For the best preventative
effect, 3gms of penicillin is given intravenously as a loading dose during labour, followed by
a maintenance dose of 1.8gms penicillin four-hourly until birth occurs (Morgan et al., 2020).
Other healthcare providers use amoxicillin instead, which is also known to have an excellent
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preventative effect (Bianco et al., 2016; Puopolo et al., 2019). Evidence reveals that adequate
antibiotic prophylaxis is reached when administered at least four hours prior to birth (Fairlie
et al., 2013). After crossing the placenta, penicillin reaches its peak concentration in the fetal
blood after one hour following administration to the woman, whereas amoxicillin has been
found in the cord blood within half an hour (Puopolo et al., 2019). The authors stated that the
blood concentrations of penicillin and amoxicillin quickly decline, approximately at four
hours and 45 minutes, respectively. This is important for administering intrapartum
antibiotics in a timely manner.
Allergy to Penicillin
In the case of penicillin allergy with low risk for anaphylaxis, cefazolin is
recommended as an alternative antibiotic (Morgan et al., 2020). Should the woman present
with a high risk for an anaphylactic reaction to penicillin, clindamycin is advised, even
though this agent is not as effective as penicillin due to its limited susceptibility (Puopolo et
al., 2019).
Adherence to the Clinical Protocol
International Rates of Adherence. The implications of adhering to the clinical
protocol of administering GBS IAP have been well studied internationally and are intricately
linked to reducing neonatal EOGBSD. For example, Russell et al. (2017) have compared
incidences of EOGBSD in cohorts of GBS colonised women who were administered IAP (n
= 13,348), and women who did not receive IAP (n = 6,649). The authors discovered a much
lower rate of neonatal EOGBSD (n = 16) in the cohort of women with antibiotic treatment
than in the group of women without it (n = 85). Further, a multistate laboratory and
population-based surveillance study revealed that 21.8% of neonates with EOGBSD were
born to women who were not administered IAP despite existing indications (Nanduri et al.,

31

2019). These are significant findings that highlight the importance of adhering to the GBS
IAP.
Adherence rates to the IAP protocol vary across studies in the global context. Kunze et
al. (2015) have identified a high rate of IAP of 89.3% for GBS positive women in their
research with a low 57.1% of these women receiving adequate antibiotic coverage (≥4 hours
prior birth). Precipitate labour and birth could be an explanation for this. Further, the results
of Gopal-Rao, Nartey et al. (2017) represent a relatively high rate of antibiotic prophylaxis
(80.7%) when indicated by a positive screening test. The majority of these women (61.9%)
were administered the adequate dose of antibiotics in a timeframe of four or more hours for
the optimal prevention of EOGBSD. Reasons for inadequate or lack of IAP were described as
insufficient time due to precipitate labour, pending screening results, no available
prescription of IAP, prescribed but not administered IAP, and cases of elective caesarean
sections.
Similarly, an Italian study stated adherence to the IAP protocol as 84.2% whilst
highlighting that only 50% of the GBS positive women received adequate antibiotic coverage
≥4 hours prior birth), 18% were not covered with the appropriate amount of antibiotics, and
32% were not administered IAP at all (De Luca et al., 2016). The authors presented several
reasons for this low rate of adequate IAP and suggesting why women did not receive
indicated antibiotics at all, including presentation to the hospital in advanced labour,
precipitate birth, and emergency caesarean sections (De Luca et al., 2016).
Nanduri et al. (2019) observed a 78.2% adherence rate to the IAP protocol, whereas
21.8% of women with an indication for IAP failed to receive it. Amongst these women, the
majority presented with no GBS screening and either developed intrapartum fever, had
prolonged rupture of membranes, or went into preterm labour. The authors did not offer an
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explanation for these missed opportunities, but findings of a study which used multistate data
from population based and laboratory based surveillance provided reasons for this
phenomenon, illustrating that in 10.4% of cases the time from admission to birth was less
than one hour making it impossible to administer IAP adequately (Verani et al., 2014).
Further, poor communication of results in cases of positive GBS status, previous GBS
infected neonate, and GBS bacteriuria was documented as reasons for no or inadequate IAP
by Verani et al. (2014).
Yamaguchi and Ohashi (2018) who investigated adherence to IAP in the context of the
midwifery led model of care, reported that the midwives of 24 of the 135 included maternity
homes where positive GBS results were detected, did not administer IAP at all to women in
labour as per the Japanese Midwives Association guidelines resulting in a compliance rate of
only 54.4%. Further, in cases where during the care for women serious complications arose,
such as prolonged rupture of membranes and fever in labour (≥ 38.0 °C), midwives ensured
ambulance transport to the hospital for further treatment and care in only 37% and 82.2% of
cases, respectively.
National Rates of Adherence. Extremely limited research is available on the
adherence to the IAP protocol in Australia. One of the two identified studies demonstrated
that in 83% of women identified as GBS positive, the antibiotic regime was followed which
involved the right choice of the antibiotic, the accurate dosage, and the right time of
administration during labour (Moorhead et al., 2019). However, a low compliance rate of
antibiotic therapy as per guidelines of only 15% was observed in the event of unknown GBS
status at birth with one or more clinical risk factors for EOGBSD present. Corresponding
findings have been demonstrated by Braye et al. (2019), identifying the rate of administered
antibiotic prophylaxis of 79% and noting that 12% of women received IAP with a negative
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GBS test result. Reasons for the latter were not provided. It is possible that in these cases
women demonstrated risk factors for EOGBSD including preterm labour, prolonged rupture
of membranes, or fever during labour (Hasperhoven et al., 2020). No report was given about
an adequate level of administration of antibiotics in labour (≥ 4 hours prior birth).
Regional Rates of Adherence. In WA, with birth rates consistently rising towards
33,754 registered births in 2019 (Government of WA, 2020) and in a multicultural society,
the achievement of excellent health outcomes for women and their babies is of utmost
importance. This includes optimal adherence to GBS IAP to prevent neonatal infection.
Currently, there are no studies that have examined the rates of adherence to the GBS IAP in
WA.
The above section has examined the crucial role of intrapartum antibiotic prophylaxis
in preventing neonatal EOGBSD including characteristics of antibiotics and the scenario of
allergic reactions to penicillin. Adherence to IAP as part of GBS guidelines presented the
main body of the discussion outlining differences between international, national, and
regional rates. No Western Australian studies have been identified in relation to this topic,
which was addressed in the current research project to fill this gap.

Conclusion
This review has discussed evidence from current literature relating to antenatal GBS
screening and management adherence levels. Various studies have examined this topic
internationally. Limited data exists in Australian settings, where no studies could be
specifically identified in relation to WA. Even more noteworthy was that worldwide only one
research study was available in the context of the midwifery led model of care. Three major
key themes relating to the research query emerged: 1) the universal GBS screening approach;
2) the controversy, and 3) intrapartum antibiotic prophylaxis. Various important subthemes
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surfaced and were discussed. The literature revealed broad differences in adherence to
universal GBS screening ranging from 15.9% to 96.8%. Some explanations could be baseline
adherences to GBS guidelines, geographical variations in GBS colonisation rates,
characteristics of diverse health service providers including private obstetricians, community
midwives, and public hospital settings; all of which will be investigated in this research
project. The ongoing debate regarding prevention methods was explored, evidencing the
efficiency of the universal GBS screening and IAP as a strategy, with a stronger impact on
the reduction of neonatal EOGBSD compared to the risk-based approach. Some studies have
argued that the intrapartum use of antibiotics may cause alterations of the neonatal gut
microbiota, which can lead to metabolic problems with long-term consequences, but evidence
for severe adverse outcomes was limited. Further, the literature demonstrated that antibiotic
resistance is a major concern worldwide but highlighted that penicillin has an excellent
susceptibility to GBS as the first line of antibiotics in the prevention of EOGBSD in neonates.
This review has discovered a wide range of adherence to intrapartum antibiotic protocols
(54.4% – 89.3%). Further, a significant gap between adequate and insufficient administration
of antibiotics was identified, with low adherence rates being particularly attributed to the
midwifery led model of care.
Based on the present limited evidence it is not possible to establish the current
prevalence of adherence to antenatal GBS screening and management guidelines nationally
and for WA, specifically in the context of the midwifery led model of care. It can only be
extrapolated from the extant research that adherence rates are potentially low, where
midwives are lead professionals in maternity care until empirical evidence has shown
otherwise. This planned research investigating adherence to GBS screening and management
in WA will attempt to fill this gap in knowledge. This information can be used to inform
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recommendations for future strategies designed to improve health outcomes for women and
babies.

Summary
This chapter presented a narrative review of the international literature relating to
adherence to antenatal GBS screening and management guidelines in the midwifery led and
the non-midwifery led model of care. A discussion of the available relevant literature was
presented using a thematic approach. The next chapter provides a description of the
methodology used to explore this topic using quantitative methods of enquiry.
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Chapter 3 – Methodology

This chapter addresses the strategies adopted to respond to the research question
articulated in the first chapter, by presenting and discussing the methodology and research
design that motivated the project. The chapter commences with a description of the relevant
philosophical and theoretical underpinnings of this research project, grounded in the positivist
paradigm. The application of the concepts of critical theory and feminist perspectives are then
explained. The second section examines the research design, discussing the strategy used for
data acquisition, preparation, and analysis. This includes a discussion of the strategies
observed to maintain ethical integrity and rigour.

Philosophical and Theoretical Foundations
The methodological underpinnings of this research study were informed by critical
theory and critical feminism. These philosophical and theoretical frameworks are discussed
separately before examining how they complement each other and why they provided the
most appropriate theoretical framework for this study.
Critical Theory
Each research project is carried out within a particular paradigm, which is also referred
to as worldview or framework of thought, guiding the researcher in interpreting reality
(Singh, 2019). Empirical social science assumptions embrace critical theory devised by
Jürgen Habermas and Georg Lukacs, who argued that economic and cultural ideological
analysis require an understanding of rational social systems and how they are perceived
(Edgar, 2017; Mambrol, 2017). Critical theory evolved from the Frankfurt School, with roots
in Germany in 1923, involving critique of social inequalities and the promotion of system
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change (Corradetti, 2012). Emancipation is at the core of critical theory (Prince & Levy,
2017), incorporating legal, political, or social liberation (Burkett, 2020). Consequently,
intrapersonal values and belief systems should be reviewed in considering environmental
social norms. In this regard, the critical theory assumption is that personal identity, reality,
and rationality requires an integration of social and environmental constraints on a person’s
freedom of decision making, which can be influenced by external factors (Abdul Rehman &
Alharthi, 2016). Therefore, critical theory extends empirical research (and vice versa) by
integrating understandings of individual levels of people’s everyday life in the context of
social phenomena so that potential change and progress related to inequalities and problems
in a system can be addressed (Sundin & Fahy, 2008).
Critical Feminism
Feminist perspectives review emancipation in an environment of social and political
dominance and gender inequality (Bohman, 2016). Hester et al. (1996) have asserted that the
central tenet of feminist perspectives focuses on women and how knowledge is constructed
by examining and challenging social, cultural and gender inequalities. Bierema and Cseh
(2003) have suggested that using a feminist lens in research means acknowledging the status
of women in society both in the past and in current times. In recent years, this lens has been
expanded to include all individuals experiencing gender-based oppression (Eagly, 2018). The
evolution of feminist organisations, women’s advocacy groups, and associations advocating
for policy changes in maternity care are all signs of women’s emancipation (Davis, 2013).
Feminist approaches in public health to date have focused on social, political and health
disadvantages based on gender (Rogers, 2006).
Combining critical theory and a feminist paradigm present an ideal framework for the
theoretical underpinnings of this study. Until recently, both these elements have been used in
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research to explore female experiences and to contribute to research that seeks to understand
how social, political, and cultural dynamics interact (Frost & Elichaoff, 2014). In the context
of the current study, socio-political and cultural shifts can be observed in the women’s
agency that is encouraged today. In the past, it was unthinkable for women to actively
participate in decision-making processes regarding their pregnancies as they were expected to
follow and trust medical orders without question (Lokugamage & Pathberiya, 2017). Even
now, this can be a common occurrence in some maternity health care institutions, where it
has been described by Diaz-Tello (2016) as “…bullying and coercion of pregnant women…”
(p 56.) This study is situated within the tenets of critical feminism, where the extracted data
has been examined in terms of environmental context, opportunities for education and
informed choice, where the potential for improvement has been based on this analysis.
Consequently, applying a critical theory and feminist perspective appears as the most
appropriate approach.
Positivism
Positivism is defined as “…knowledge based on observed facts gained through
scientific investigation” (Nelson, 2014, p. 1437). Research in the health profession has
traditionally been guided by a positivist paradigm that emphasises objectivity and scientific
evidence, although traditionalists have come to acknowledge a place for qualitative methods
as well (Whitehead & Schneider, 2016). While quantitative researchers may advocate that
their methods facilitate the examination of data and documentation of empirical ‘truth’,
qualitative colleagues could argue that understanding people’s perspectives associated with
numerical data is also worthwhile (Curtis & Drennan, 2013). This study embraces positivism
as it is deemed the most fitting paradigm to answer the research questions. This project has
had the opportunity to apply a comprehensive data set related to child-bearing women in
various practice settings across WA to provide context and information about support
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opportunities for choice. This methodological underpinning addresses the objectives of this
project within a critical feminist framework but using a positivist approach.

Methods
Quantitative Approach
Quantitative research is measurable and systematic and is defined as the process of
measuring numerical data to examine patterns or trends and to explore causal relationships
between variables resulting in generalisation of findings to wider populations (Creswell &
Creswell, 2018). The purpose of quantitative research is described by Whitehead and
Schneider (2016) as testing hypotheses and theories while applying control and observation.
This study’s research problem was considered to be most appropriately examined using
quantitative methods due to the nature and quality of the data available, and which was
determined as appropriate to answer the research questions.
Research Design
One of the main categories of quantitative research designs is nonexperimental research
which “…is also referred to as descriptive or observational research because the variables are
described or observed as they happen to occur” (Plano Clark & Creswell, 2017, p. 195). This
study’s research design was best characterised as observational, using secondary data analysis
to describe the patterns and trends of Group B Streptococcus screening adherence in
midwifery and non-midwifery led models of care.
Secondary Data Analysis. Secondary data analysis was used as the research method in
this study, applying already available administrative health data. Available clinical
information was analysed and interpreted with the aim of answering the research question.
Clinical Data Mining (CDM) is a specific form of secondary data analysis, where Ryan and
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Nilsson (2011) define it as: “the use of available client and agency information… to answer
research questions about practice, particularly as related to intervention and its outcomes” (p.
142). This type of data mining is commonly used to obtain information from practice to
provide practice-based evidence in an attempt to develop best practice approaches (Ryan &
Nilsson, 2011). One of the advantages of CDM is that original data is already generated and
can be non-intrusively used in subsequent research with limited ethical concerns (Ryan &
Nilsson, 2011).
Large administrative electronic datasets have widespread applications in public health
research (Franke et al., 2016). In recent years, the healthcare industry has increasingly
generated large amounts of electronic data for record keeping in patient care, towards the
promise of improved health care, better health outcomes and reduced costs (Raghupathi &
Raghupathi, 2014). Large data sets in healthcare research, combined with the use of
predictive analytic techniques, has become an enormously effective concept for predicting
individual behaviours leading to improved decision making, “… i.e., future insights, based on
a full picture of associations, for example, across time or a wide geographic area, or observed
in a substantial fraction of an entire population.” (Lee & Yoon, 2017, p. 6).
Electronic health data containing information about pregnancies from 1 January 2015 to
31 December 2019 were systematically examined and differences between the two target
groups as well as subgroups including Midwifery Group Practice, the Community Midwifery
Program, and the group of Private Midwives were explored. As shown in Figure 1, the
following five steps were involved in the process of obtaining and preparing the data for
analysis:
1.

Research sites were located, and accessibility of data was assessed. Research sites
comprised five hospitals across WA, including the tertiary maternity centre of WA,
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as well as metropolitan and regional hospitals. These divergent research sites
provided large and diverse samples which represented approximately 13% of the
proportion of all births which occurred in WA during the five years. Data
custodians of all five hospitals and an application specialist at WA Health Support
Services (HSS) were approached, where their support was secured.
2.

Research protocols were developed and ethical, governance and site approvals
were obtained for data release from HSS involving the included hospitals.

Process of Obtaining Ethical and Governance Approval. The centralised Research
Governance Service (RGS) information technology system was used in this study, in
accordance with processing all research ethics and governance applications involving WA
public health organisations (WA Department of Health, 2020c). Research protocols were
forwarded to apply for multi-centre ethical approval, governance and site authorisation as
well as data custodian permission, and submitted with supporting documents to the Women
and Newborn Health Service Ethics Committee as a WA Health Lead Human Research
Ethics Committee (HREC) via RGS. Ethics approval for the study was also sought from
Edith Cowan University’s (ECU) Human Research Ethics Committee. Data were released
from all five hospitals following ethical, governance, and site approval. The HREC approval
number from the lead ethics committee is RGS0000003723 and from ECU REMS 201901008 (see Appendices A and B).
Ethical Considerations. While carrying out the research, the guidelines of the
Australian National Statement on Ethical Conduct in Human Research and the WA Health
Research Authorisation and Monitoring guidelines were adhered to, ensuring proper ethical
conduct (Richardson-Tench et al., 2018).
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Confidentiality of organisations was preserved using numerical identifiers.
Furthermore, obtained datasets were de-identified and all data were handled following the
requirements of the National Health and Medical Research Council (NHMRC) published in
the National Statement on Ethical Conduct in Human Research 2007 (updated 2018). This
included the request to HSS for allocating pregnancy ID numbers as well as de-identifying
details of and allocating specific codes to the specific sites from where data was obtained, e.g.
Hospital 1 (H1). All information was presented in aggregated form.
3.

After data were obtained, a significant process of data cleaning and preparation
took place, which is explained in the analysis section.

4.

A new database was created using the software program Microsoft Excel and SPSS
version 26. This involved the development of specific variables to identify nonmidwifery and midwifery led care groups and their subgroups.

5.

Data were analysed applying comparative descriptive statistics to observe specific
patterns relevant to the research question (see analysis section).
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Figure 1
Model of the Clinical Data Mining Process

Data sources. This study utilised electronic administrative health data, re-purposing
existing electronic health records extracted from a database identified as Stork. Stork is the
clinical perinatal database used by all WA public health maternity services, including
homebirth providers, to record point-of-care details related to care during pregnancy, birth,
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and the postnatal period (WA Department of Health, 2016). This state-wide surveillance
system is maintained by local data custodians and governed by the health department. It is
mandatory for caregivers to enter information related to GBS screening in pregnancy. The
study population of Hospital 1 included both, midwifery led and non-midwifery led models
of care, whilst the study population of Hospitals 2, 3, and 4 comprised the midwifery led
model of care only. The rationale behind this related to the enormous number of births of the
non-midwifery led model of care group at Hospital 1 (15,268 vs 11,140 of the total number of
midwifery led model of care group of all five hospitals). Data from Hospital 5 contained birth
records from both models of care as MGP commenced only in 2017. The choice of multi-site
research rather than a single site research study provided for a much larger sample and thus
findings that are more likely to be generalisable.
Hospital 1 (H1). This hospital was chosen because it represents the largest number of
women cared for by both provider types under study and includes all care levels from low to
high risk. It is WA’s first maternity hospital, founded in 1916 where it counted 304 births in
its first year. Currently, it welcomes more than 6,000 babies per annum into the world, which
accounts for approximately 20% of all babies born in WA. For many decades, it has been
WA’s only tertiary maternity and gynaecological hospital, where the majority of the State’s
complex and high-risk women have been referred to for high standard maternity and
gynaecological care. This hospital is home to a state-of-the-art neonatal intensive care unit,
which is recognised as “…the largest in the southern hemisphere”, caring for more than 2,000
premature and sick neonates every year (Source H1, 2020, para. 4).
For the first time in WA history, a Family Birth Centre was opened at the H1 site in
1992, offering midwifery led care in a home-like environment to women with low-risk
pregnancies with an annual average of 280 births (WA Government, 2017). In 2013,
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midwifery led care by MGP was introduced at the Family Birth Centre providing continuity
of midwifery care throughout pregnancy, labour, birth, and the postnatal period. This means
that women can receive care from the same midwife from the start of their pregnancy through
to the period after their baby is born. MGP expanded to the main hospital in 2016, to offer
this continuity of midwifery care to women with medium to high-risk pregnancies.
In 1996, another midwifery led model of care was established under the governance of
the hospital, the Community Midwifery Program (CMP), which “…is the only publiclyfunded home birth program of its kind in Australia…”, providing community based care to
approximately 400 low-risk pregnant women every year (Source H1, 2018, para. 2). In the
CMP, midwives promote normal birth, where participating women have the choice of giving
birth at home, at the Family Birth Centre, in the Birthing Rooms, or in the hospital whilst
cared for by their CMP midwife. In recent years, CMP has developed a risk model to be able
to offer continuity of care to women with specific risk factors including previous caesarean
section, previous postpartum haemorrhage, previous shoulder dystocia, previous retained
placenta, previous stillbirth at term and grand multiparity (Source H1, 2019).
The group of private midwifery practices independently and usually care for women
who birth at home. However, admission rights to hospitals exist and can be used if labour and
birth complications arise. If a private midwife has no admission rights but still needs to
present at the hospital due to an emergency, the midwife can attend as a support person whilst
the woman receives care from a hospital midwife and obstetric team. Therefore, multiple
birth record data sets from the population of Hospital 1 in this study included women who
received antenatal care by a privately practising midwife who then attended Hospital 1 for
labour or birth. This is important because education about GBS colonisation and screening is
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recommended during the third pregnancy trimester and; therefore, as part of antenatal care
provided by the private midwife.
Five Excel data files were received from HSS containing a total number of 22,342 data
sets for Hospital 1. Of these, 15,268 data sets represented the non-midwifery model of care
and 7,074 data sets represented the midwifery led model of care.
Hospital 2 (H2). This hospital was established in 1929 and was initially privately run.
With only one general bed and four maternity beds, it was declared a public hospital by an
Act of Parliament in 1948 (Source H2, 2020a). Throughout the decades, the facility was
extended and modernised with a newly built maternity wing opened in 1971, providing 32
beds with a capacity of at least 2,400 births each year (Source H2, 2020a). At this hospital,
women can choose from a range of maternity care options with care during pregnancy and
birth from midwives and doctors on duty at the hospital, care provided by GP obstetricians,
and care offered by midwives of the MGP (Source H2, 2020b). The MGP, which is the
midwifery led model of care at Hospital 2, is comprised of four teams with five midwives in
each group providing care at a low to medium risk level and helping more than 500 babies to
be born every year. One Excel data file was received from HSS containing 2,608 data sets of
the MGP model of care.
Hospital 3 (H3). This regional hospital possesses an interesting past. It was first built in
the 1960s on a parkland with attractive gardens displaying many large trees, as part of the
promotion of James Grady’s ‘total health’ philosophy (Source H3, 2017). As one of the
tallest buildings at the time, it was demolished after 33 years of service and the hospital was
relocated and positioned alongside a private hospital in the South West Health Campus
(Source H3, 2017). Women of Hospital 3 can access several maternity services in partnership
with General Practitioners, private obstetricians, Aboriginal health services and metropolitan

47

hospitals. This includes team midwifery care, public hospital maternity care, GP Obstetrician
care, community midwifery/shared care and MGP care (WA Country Health Service, 2011).
One Excel data file was received from HSS containing 554 data sets of the MGP model of
care.
Hospital 4 (H4). This hospital is the major resource centre providing various health
care services to residents and a growing number of tourists in the Kimberley region located in
the most northern part of WA. The Kimberley region’s population consists of approximately
30% Aboriginal and Torres Strait Islander peoples and is home to multiple Aboriginal
communities (Statewide Obstetric Support Unit, 2020). Four years ago, a major
redevelopment of the hospital resulted in a refurbished maternity unit including two birthing
suites, nine maternity beds and an adjacent level two Special Care Nursery catering for
women with low to medium risk pregnancies (WA Department of Health, 2020a). The MGP
model of care was implemented in 2012 by a midwife who moved there from the Northern
Territory, where it now has two teams of midwives assisting an average of 170 women each
year (Waddell, 2017). One Excel data file was received from HSS containing 833 data sets of
the MGP model of care.
Hospital 5 (H5). This regional hospital is the key health service for the district of the
Western Wheatbelt and – although small – offers a range of health services including hospital
care and community health services for more than 70,000 residents in over 40 local
governments (Rural Health West, 2020). Until June 2015, a long-serving obstetrician
delivered approximately 50 babies each year using the maternity facilities at the hospital,
consisting of two birthing suites and a family sitting room (Hildebrandt, 2017). Following his
retirement, pregnant women in the Wheatbelt region were provided antenatal care by an
outpatient service attending obstetrician and when in labour cared for by the hospital’s
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emergency team who organised transport to the nearest hospital (Hildebrandt, 2017). This
was a difficult situation for expectant parents in the Wheatbelt, some of whom had the
distressing experience of their baby being born by the side of the road since the closest
hospital was a one to two-hour drive away (Hildebrandt, 2016). The Wheatbelt MGP was
initiated following unsuccessful efforts to replace the retired local obstetrician and was
commenced in 2017 to provide midwifery continuity of care to women with low risk
pregnancies as well as shared care during the antenatal and postnatal period in the case of
complicated pregnancies (WA Country Health Service, 2017).
For this study, one Excel data file was received from HSS comprising 71 data sets
which contained a combination of pregnancy records of the midwifery led model of care as
well as the non-midwifery led model of care.
Study Population. The population of interest for this study was pregnant women
whose pregnancy resulted in a live birth at term (from 37 weeks gestation) and who received
antenatal care in WA from midwifery led and non-midwifery led care providers. The
women’s age ranged from 13 to 53 years, representing 169 different countries of birth. Other
demographics included the number of pregnancies, which ranged from 1-20 as well as the
number of previous livebirths ranging from 0-12. Included births occurred in metropolitan
and regional hospitals, a birth centre and at home, between 1 January 2015 and 31 December
2019.
Via secure email, HSS provided nine separate Excel spreadsheets containing a total
number of 26,408 data sets as shown in the following table (Table 1).
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Table 1
Details of Received Data Sets (January 2015 – December 2019)
Hospital

Midwifery Led
Model of Care

Non-Midwifery Led
Model of Care

1

7,074

15,268

2

2,608

-

3

554

-

4

833

-

5

48

23

11,117

15,291

Subtotal
TOTAL
26,408

Analysis
Data Quality Assessment and Data Cleaning Process
The assessment of the quality of collected data, particularly in multi-site research, is of
utmost importance “…to distinguish true variations in care from data quality problems.”
(Kahn et al., 2012, p. 21). Data quality assessment, cleaning and preparation were conducted
in numerous steps. The researcher requested data from HSS with a clear exclusion criterion.
Pregnant women who underwent elective caesarean section were excluded because GBS
screening is not recommended in this case, due to the low risk of neonatal infection.
However, HSS sent data with the inclusion of elective caesarean sections and provided a total
sample of 26,408 data sets. In the process of cleaning and preparing the data, all data sets that
indicated that the type of birth was an elective caesarean section were removed (3,941),
where a total of 22,467 data sets remained.
Nine separate Excel files with site-specific data sets (H1 = 5 files, H2 = 1 file, H3 = 1
file, H4 = 1 file, H5 = 1 file) were combined into one multi-site data file for analysis, which
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was performed in the Excel program. It was impossible to analyse the Excel format in which
the data were provided by HSS. It has been a time-consuming, complicated and at times
somewhat frustrating process to achieve this goal of organising and cleaning the data. The
issues and steps taken for problem solving are summarised as follows:
1.

The pregnancy records did not contain unique event identifiers. Upon request, the
data provider HSS allocated pregnancy IDs to each pregnancy data set.

2.

The Excel data extracts/files sent by the data provider were not event-level.
Instead, some data rows contained variables embedded within a split cell. This
means, the data presentation was a mix between event-level data and a table
making it impossible to merge. HSS was not able to change the data layout due to a
lack of resources available. Therefore, in the data cleaning process, every data set
was modified to an event-level data set using SAS re-coding techniques (see syntax
in Appendix C).

3.

All H1 data sets (five files) contained an additional variable (MGP as antenatal
care team), which was not present in the data files of other hospitals. This variable
was removed from all H1 data files as it was not imperative for analysis.

4.

49 data sets were removed because they indicated that no antenatal care was
attended.

5.

One H1 data set was identified with missing values and was removed from the
analysis.

6.

Thirty records in the H1 population genuinely involved two provider types (MGP
and CMP as well as MGP and PM). These data sets were only used in the analysis
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when comparing midwifery and non-midwifery led model of care groups and were
not included in the analysis of the subgroups.
7.

Nine H3 MGP data sets did not contain evidence indicating midwifery led care.
The application specialist at HSS was contacted who provided clarification that the
nine records were true MGP records.

8.

The H5 data sets were a combination of records from the midwifery led and nonmidwifery led model of care. Four of the designated midwifery led care records
were identified as non-midwifery led model of care records which was confirmed
following email conversations with HSS. These were then added to the nonmidwifery model of care group for analysis.

9.

Several variables had to be created involving a process of recategorisation to
identify the two main target groups and all specific subgroups and including
variables that summarised any CMP involvement (x_cmp_any), any MGP
involvement (x_mgp_any), and any private midwife involvement (x_pm_any) as
well as the variable x_datafix_mgp, for the MGP data records which did not show
a clear mention of midwifery involvement in the antenatal care variables but were
confirmed as true MGP records by HSS.

Variables in the Study
Variables in research refers to measurable factors with certain attributes/values or
characteristics that vary (Plano Clark & Creswell, 2017). Resulting from the data cleaning
process, the following variables were identified in this study:
Independent Variables. An independent variable is described as what is expected to
influence the dependent variable (Creswell & Creswell, 2018). This study used several
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independent variables which were of principal interest exploring their potential impact on the
dependent variable and included the midwifery led model of care, the non-midwifery led
model of care, and specific subgroups (MGP, CMP, PM). Other independent variables were
maternal age, parity, country of birth of the mother, and appropriate antibiotic prophylaxis.
Dependent Variable. The values of a dependent variable, also called outcome,
response, or criterion variable, are dependent on or “…predicted by the independent variable,
whether or not they are caused by it” (Vogt, 2005, p. 86). In this study, the dependent
variable was the GBS test result demonstrating the adherence to GBS screening guidelines
containing the following values: positive, negative, result pending, not tested this pregnancy,
and declined by woman.
Data were analysed using the Microsoft Excel spreadsheet program and the statistical
software package SPSS Version 26. Descriptive statistics were applied to summarise the data
and for exploring maternal demographics. Frequencies for the overall rate of GBS
colonisation in pregnancy amongst the different population groups were examined,
specifically screening test particularities of negative, positive and pending GBS results, as
well as cases where the screening test was not performed and/or declined by the woman. The
adherence rates of antenatal GBS screening amongst all women, main and subgroups were
identified, where distribution and central tendency was investigated. It was examined whether
trending characteristics exist regarding GBS screening adherence in both models of care
(midwifery and non-midwifery led) over the five-year period. Further, it was investigated if
the dependent variable (GBS test result) varied according to subgroups (MGP, CMP, PM).
Using the same analytic methods, the adherence to intrapartum antibiotic prophylaxis was
examined. Outcomes were measured and reported numerically as percentages and counts and
displayed in bar and line graphs to demonstrate proportional differences.
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Data Management and Security
All data were securely handled according to ECU’s Human Research Ethics
Committee’s protocol. Multi-site electronic data collected as a single extract from the WA
Health Department were securely stored on the cloud data storage software BOX for the
purpose of supervision and assistance in the data analysis. This cloud service is used and
provided at ECU and enables secure file sharing between the student and named supervisors.
Box operates on a zero-trust model protecting the data directly. This includes measures to
protect all content with security bots, advanced authentication techniques such as one-time
passwords, and out-of-band approval for sensitive tasks. To achieve excellence in data
security regular data backups were performed.
In alignment with The Australian Code for the Responsible Conduct of Research and
ECU Research Data Management Policy, the information management team at ECU
registered the data management plan submitted in the record keeping system so that original
plans were protected and remain accessible over time. A unique research project number was
applied to the project (2019-01008), from inception through to project completion, until such
time the project is due to be disposed of. A folder structure was established to help organise
the various types of data produced throughout the project. It will be ensured that the primary
copy of the data retained is made available to Information Management and Archive Services
(IMAS) who manage data retention on behalf of ECU. Data will be stored for seven years in
accordance with ECU’s data management policy. The data will be disposed of according to
the Western Australian University Sector Disposal Authority guidelines.
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Rigour
Validity
Whitehead and Schneider (2016) have emphasised two concepts by which the quality
of quantitative research can be assessed: reliability and validity. External validity implies the
ability to generalise results (Richardson-Tench et al., 2018). The exhaustive process of data
cleaning, preparing and primary analysis in this study ensured that only appropriate variables
were utilised and that the analysis was valid. The degree of external validity of this study is
high because of the chosen type of sample that was drawn from a diverse population of
pregnant women. The large sample of 26,408 women represents women of any background
who received maternity care from various health care providers at five different hospitals in
metropolitan and regional Western Australia. The timeframe of the collected data is a fiveyear period (2015-2019). All these features rule out selection and allocation bias whilst
strongly and positively contributing to the capacity for generalisation of the study’s findings.
Descriptive validity is a relatively new but increasingly popular means of determining
the rigour of a research project (Bergin, 2020). This type of validity refers to a provision of
detailed and accurate descriptions of how data was collected and analysed, which also can
assist in replicating the methods and results in future research (Bergin, 2020). This study
offers a comprehensive description of the data collection and analysis processes ensuring its
robustness and rigour.
Reliability
Reliability is the other quality measure in a quantitative research study. It “…refers to
the reproducibility of the results of a measurement technique” (Richardson-Tench et al.,
2018, p. 154) and the consistency of the applied measure (Heale & Twycross, 2015). The
degree of reliability in this study is strong because administrative electronic health data of
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26,408 women were analysed using the same maternity database, representing consistency
across the data. Approved statistical analysis techniques were applied including frequency
distribution and measures of central tendency using Excel and SPSS software programs. The
process of data collection and analysis has been clearly detailed in this report, providing a
trail for any future research to follow and arrive at the same results using this database,
further demonstrating the reliability of the work. This transparency as Rotelli (2015)
advocates, is an important requirement for establishing strong reliability in retrospective
analysis of administrative healthcare data.

Summary
This chapter discussed the methodology of this research project commencing with a
description of the philosophical and theoretical underpinnings which was followed by a
rationale for selecting the quantitative approach for this study. The advantage and application
of secondary data analysis was highlighted, where quantitative methods were outlined. The
second section examined the research design starting with a description of the process of
obtaining ethical, governance and site approval and then discussed the strategy of data
acquisition, the analysis including the complex process of data cleaning and preparation. A
brief discussion of the study’s rigour was provided. In the following chapter the findings will
be presented.
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Chapter 4 – Results

This chapter presents the results of the study. It commences with a description of the
sample including the demographic characteristics of the pregnant women under study. This is
followed by reporting on specifications of Group B Streptococcus (GBS) colonisation rates in
the two comparison groups (i.e. midwifery and non-midwifery led models of care). Then the
prevalence of adherence to antenatal GBS screening guidelines in all groups and subgroups
under investigation, including trends in adherence over the five-year study period are
presented. As the final part of the analysis, the adherence to the Intrapartum Antibiotic
Prophylaxis (IAP) protocol among all groups is described. The chapter concludes with a
summary of the findings some of which were unanticipated and surprising.

Sample
The sample for this study consisted of 22,417 pregnant women. The following section
provides a description of the maternal demographics of the whole sample commencing with
statistics on the age of mothers at birth, country of birth, gravidity, and parity.
Maternal Demographics
Maternal Age. The women’s ages ranged from 13 to 53 years (M = 30.1). Its
distribution was found to vary widely as is illustrated in Figure 2. The youngest woman
giving birth was 13 years old presenting the only one in this age category. In contrast, the
highest age of a birthing woman was 53 years, which also accounted for the only participant
in this age group. Women within the 26 – 35 year age bracket covered the largest number
ranging from 1,106 to 1,746 women per year. The numbers per year were found to be steadily
declining from the age of 36 to 42 (n = 926 to 111) whilst the number of women who gave
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birth older than this (43 to 51) was low with under 100 women per year. The age distribution
of all the pregnant women under study is provided in detail in Appendix D.
Figure 2
Age Distribution of all Women Under Study

Country of Birth. The women, who all birthed in WA during the time period of this
study, demonstrated a vast multicultural background. They represented 169 different
countries of birth with just over half of the women having been born in Australia (55.52%, n
= 12,445). The various countries were grouped into six geographic regions according to the
WHO’s recommendation (WHO, n.d.) as illustrated in Figure 3. The African region
represented 1,039 women (4.63%), the Eastern Mediterranean region 912 (4.07%), the
European region 2,807 (12.52%), the region of Americas 603 (2.69%), the South-East Asia
region 1,859 (8.29%), and the Western Pacific region the highest number of 15,186 women
(67.74%). For 10 women (0.04%) the country of birth was not available. A detailed
description of the countries’ categories can be found in Appendix E.
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Figure 3
Geographic Regions of the Whole Study Population

Gravidity. The gravidity2 of women in the study population varied greatly ranging
from 1 to 20 pregnancies (M = 2.47). More than a third of women (n = 7,645, 34.10%) had
one pregnancy with 6,530 (29.13%) presenting with their second. A stark decline was
observed with women presenting with third pregnancies of only 3,843 (17.14%), and the rate
of women with a history of four and more pregnancies was below 10%. The data did not
specify how many of these pregnancies resulted in livebirths, stillbirths, miscarriages,
abortions, and medical terminations. The details of pregnancies across the whole population
are presented in Appendix F. The distribution of pregnancies is also illustrated as percentages
in a pie chart in Figure 4.
Figure 4
Distribution of Pregnancies in the Whole Population

2

Number of pregnancies
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Parity. Parity, another demographic characteristic of the pregnant women under study,
refers to the total number of previous births (as opposed to the number of times she has been
pregnant). Parity includes nullipara for zero births, primipara for one birth, multipara for
greater than or equal to two births, grand multipara for greater than or equal to five births,
and great grand multipara for greater than or equal to ten births whereas women with four or
less previous births are considered having a low parity and with five and more a grand
multiparity (Eugene & Abedinego, 2017). The analysis revealed a wide range of previous
births from 0 – 12. The highest number of women were nulliparous (n = 10,682, 47.65%)
followed by a high number of women who had one previous birth (n = 6,879, 30.69%). The
group of women with a history of two births was much smaller with 2,923 (13.04%) and
declined further to 1,069 (4.77%) in the cohort of women who had given birth the third time.
The number of women with four and more previous births was small at less than 2%, and one
woman was identified who had birthed 12 children. No specifications were provided in the
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data about whether the previous births were livebirths or stillbirths. Table 2 illustrates these
details.
Table 2
Details of Previous Births
Parity

n

%

0

10,682

47.65

1

6,879

30.69

2

2,923

13.04

3

1,069

4.77

4

441

1.97

5

224

1.00

6

108

.48

7

45

.20

8

26

.12

9

9

.04

10

7

.03

11

3

.01

12

1

.00

22,417

100

TOTAL

Comparison of Models of Care. In the following, maternal demographics are
examined according to the two models of care: midwifery led and the non-midwifery led
model of care. As will be shown, no remarkable differences were found. The results compare
maternal age, country of birth, gravidity, and parity.
Maternal Age. A comparison of the maternal age distribution in the two models of care
revealed no differences. The age range for the midwifery led model of care was 13 to 53
years (M = 30.3) whereas it was 14 to 53 years (M = 29.93) for the non-midwifery led model
of care (see Figures 5 and 6).
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Figure 5
Maternal Age Distribution in the Midwifery Led Model of Care

Figure 6
Maternal Age Distribution in the Non-Midwifery Led Model of Care

Country of Birth. The majority of women of both care models were born in countries
of the Western Pacific region with 70.85% (n = 74.54) of women of the Midwifery Led Care
(MLC) group and 65% (n = 7,732) of the Non-Midwifery Led Care (NMLC) group. There
was little difference with some divergence in women having been born in the South-East
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Asian region (11.57%, n = 1,376 vs. 4.59%, n = 483) and European region (16.38%, n =
1,723 vs. 9.11%, n = 1,084). Even smaller was the difference for women with their birth
country grouped in the regions of Americas with 3.27% (n = 344) for the MLC model and
2.18% (n = 259) for the NMLC model. The percentage of women having been born in the
African region was comparable in both groups with 3.37% (n = 355) in the MLC model and
5.75% (n = 684) in the NMLC group. A small contrast was identified when comparing
women with the country of birth in the Eastern Mediterranean region with a low 1.47% (n =
155) in the MLC group versus 6.36% (n = 757) in the NMLC cohort. Figures 7 and 8
illustrate the geographical regions of the two models of care.
Figure 7
Geographical Regions in the Midwifery Led Model of Care

63

Figure 8
Geographical Regions in the Non-midwifery Led Model of Care

Gravidity. No major differences were identified between the two models of care in
relation to gravidity. Whilst it ranged from 1 – 18 (M = 2.24) in the midwifery led model of
care, corresponding numbers of pregnancies were observed in the non-midwifery model of
care (n = 1 – 20, M = 2.67). Appendix G presents these numbers in detail.
Parity. Similar to gravidity, the numbers in the two models of care did not differ much
at all when parity was compared. It was observed that women in the midwifery model of care
had between 0 – 11 previous births (M = 0.75) whereas parity ranged from 0 – 12 (M = 1) in
the non-midwifery care population (see Appendix H for more parity details).
Data Distribution
The sample of this study comprised data of the two models of care across five hospitals
in metropolitan and regional Western Australia. The proportion of women receiving
midwifery led care was slightly smaller (46.92%, n = 10,519) compared to 53.08% (n =
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11,898) of women receiving non-midwifery led care. Importantly, the vast majority of data
were derived from Hospital 1 with 83.19% (n = 18,648). The rate for Hospital 2 was 10.71%
(2,400), which was substantially higher than for Hospital 3 with 2.40% (n = 539) and
Hospital 4 with 3.39% (n = 759). The smallest proportion of data with 0.32% (n = 71) was
identified for Hospital 5. Table 3 provides an overview of these compositions.
Hospital 1 comprised the two different models, with 36.33% (n = 6,773) of women in
the midwifery led care group and a higher proportion of women receiving non-midwifery led
care (63.67%, n = 11,875) (see Figure 9). It was the only hospital representing other
subgroups of the midwifery led care model which included the MGP as the largest group
among them (81.60%, n = 5527), the CMP with 14.88% (n = 1,008), and the group of PM
with a small proportion of 2.49% (n = 168). Seventy records (1.03%) were not analysed
across these subgroups as they genuinely involved two or more subgroup provider types. This
means that 27 records reported women receiving shared care by the MGP and CMP, while 35
women received care by MGP and PM, seven women were cared for by CMP and PM. One
woman was provided maternity care from all three care providers. Details of this distribution
are presented in Table 3.
As presented in Figure 9, apart from Hospital 1 and 5, data received from all other
institutions referred to midwifery led care exclusively, with Hospital 5 providing less than
half of their pregnant population (n = 23/71) non-midwifery led care.
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Table 3
Compositions of Analysed Data Sets
H1
n (%)

H2
n (%)

H3
n (%)

H4
n (%)

H5
n (%)

Total
n (%)

Midwifery led

6,773
(36.33)

2,400
(100)

539
(100)

759
(100)

48
(67.60)

10,519
(46.92)

MGP

5,527
(81.60)

2,400
(100)

539
(100)

759
(100)

48
(100)

CMP

1,008
(14.88)

-

-

-

-

-

PM

168
(2.49)

-

-

-

-

-

Minus inconclusive
records

70
(1.03)

-

-

-

-

-

Non-midwifery led

11,875
(63.67)

-

-

-

23
(32.39)

11,898
(53.08)

18,648
(83.19)

2,400
(10,71)

539
(2.40)

759
(3.39)

71
(0.32)

22,417
(100)

Study Population

TOTAL

Figure 9
Overview of Sample by Model and Data Source (H1 – H5)
12,000

11,875

10,000

Number of Women

8,000

Non-Midwifery Led
Model
Midwifery Led Model

6,773

6,000

4,000

2,400

2,000

0
0

0

539

0

759

23

48
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Prevalence of GBS Colonisation
The prevalence of GBS colonisation within the whole population under study included
the evaluation of the two major cohorts, and subgroups.
Whole of Study Population
The GBS colonisation rate of all pregnant women who received GBS screening was
found to be 21.70% (n 3,907) (see Table 4).
Comparison of Models of Care
Comparable rates of GBS colonisation were identified in the two care models with
20.32% (n = 1,470/7,234) in the midwifery led model of care and slightly higher results in the
non-midwifery led model of care reportedly at 22.63% (n = 2,437/10,765). This outcome is
illustrated in Table 4.
Table 4
Prevalence of GBS Colonisation in the Whole Study Population
Study Population

Women Tested

GBS Positive

n

n

%

Whole Population

17,999

3,907

21.70

Midwifery led model
of care

7,234

1,470

20.32

Non- midwifery led
model of care

10,765

2,437

22.63

Comparison of Subgroups
In the following, different subpopulation results in relation to GBS colonisation is
presented.
MGP Population. Of the GBS tested women in this population (n = 6,631), 1,341
(20.22%) women were identified with GBS colonisation. When the colonisation rates among
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pregnant women of the MGP groups in all five hospitals were compared, varying results were
found. Of the 3,166 GBS tested pregnant women in Hospital 1, 698 (22.04%) women were
colonised with GBS. In Hospital 2, of the 2,279 MGP women who received the GBS
screening, a slightly lower rate of 428 (18.78%) women had GBS similar to the 427 GBS
tested MGP women in Hospital 3 with 72 (16.86%) and Hospital 4, where of 727 tested
women 136 (18.70%) women were colonised with GBS. Comparable GBS colonisation rates
were found among the MGP population in Hospital 5 with 21.87% (n = 7) of 32 tested
women. These findings are presented in Table 5.
Table 5
Prevalence of GBS Colonisation Amongst MGP Groups
MGP Cohorts

Women Tested

GBS Positive

n

n

%

All MGP women

6,631

1,341

20,22

MGP H1

3,166

698

22.04

MGP H2

2,279

428

18.78

MGP H3

427

72

16.86

MGP H4

727

136

18.70

MGP H5

32

7

21.87

GBS Colonisation Rates among Subgroups of H1. Further investigation was
conducted among the subgroups of the midwifery led models of care in Hospital 1 revealing
comparable results. An overall GBS colonisation rate of 21.96% (n =819) of all 3,729 GBS
tested women was found in this cohort of subgroups. In comparison, with a GBS colonisation
rate of 22.04% (n = 698) in the MGP cohort (n = 3,166), it was revealed at 20.85% (n = 102)
of all 489 tested women in the CMP population and slightly higher with 25.67% (n = 19) of
74 women who received GBS screening in the PM group. Table 6 presents these results.
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Table 6
Prevalence of GBS Colonisation Amongst Subgroups
Subgroups

Women Tested

GBS Positive

n

n

%

All subgroups

3,729

819

21.96

MGP

3,166

698

22.04

CMP

489

102

20.85

PM

74

19

25.67

Prevalence of Adhering to Antenatal GBS Screening
This section provides a detailed description of the prevalence of adhering to the
recommended antenatal GBS screening commencing with adherence rates among all women
under study, followed by a comparison of rates in the two models of care which includes a
display of trends over the five-year period, followed by an investigation of GBS adherence
rates among all subgroups.
Whole of Study Population
The vast majority of the pregnant women had the GBS screening test administered
(80.29%, n = 17,999) indicating that 19.71% of all women (n = 4,418) did not receive the
screening test in pregnancy. The data further revealed that 17.43% (n = 3,907) of tested
women were identified with GBS positive result whilst more than 50% of this group had a
negative GBS screening result (59.33%, n = 13,300). A small percentage was detected with
GBS results still pending at the time of birth (3.53%, n = 792). Figure 10 illustrates these
findings.
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Figure 10
Details of Antenatal GBS Screening in the Whole Population Under Study

All Women
n = 22,417
(100%)
GBS Screening

No GBS Screening

n = 17,999

n = 4,418

(80.29%)

(19.71%)
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GBS Negative

Results Pending

n = 3,907

n = 13,300

n = 792

(21.70%)

(73.89%)

(4.40%)

Comparison of Models of Care
In the following, antenatal GBS screening adherence is examined according to the
midwifery led and the non-midwifery led model of care. As will be shown, remarkable
differences were discovered.
In the midwifery led model of care population (n = 10,519), a low rate of adherence to
GBS screening was found (68.76%, n = 7,232) compared to a much higher rate of 90.49% (n
= 10,767) in the group of pregnant women cared for by the non-midwifery led model of care
(n = 11,898) (see Figure 11). This means that 31.24% (n = 3,287) of pregnant women in the
midwifery led care model were not tested for GBS colonisation in pregnancy, in contrast to
9.50% (n = 1,131) in the non-midwifery led model of care. On examination of the GBS
results of tested women in the two models, 13.97% (n = 1,469) in the midwifery led model of
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care tested GBS positive with a slightly higher rate of 20.49% (n = 2,438) in the nonmidwifery led model of care. Comparable findings emerged in the two groups when GBS
negative results were investigated with 53.58% (n = 5,636) in the midwifery led care model
and 64.41% (n = 7,664) in the non-midwifery led model of care. The rate of pending results
at the time of birth were similar with 1.21% (n = 127) in the midwifery led and a slightly
higher 5.59% (n = 665) in the non-midwifery led group.
Figure 11
Prevalence of Adhering to GBS Screening
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Evaluation of the screening trends in antenatal GBS screening characteristics over the
five years for both care provider groups was conducted. This revealed a notable increase in
the rate of the midwifery led women not tested for GBS colonisation from 21.35% (n = 349)
in 2015 to 36.34 % (n = 847) in 2019. In contrast, in the non-midwifery led care model, the
rate of women not tested was low, revealing an unremarkable rise from 8.85% (n = 234) to
9.52% (n = 216). The GBS positive rate was found trending low over the years from 15.60%
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(n = 255) to 12.61% (n = 294) in the midwifery led care models, and from 21.81% (n =577)
to 18.46% (n = 419) in the non-midwifery led care group. The rate of women tested GBS
negative was notably declining in the midwifery led models of care from 61.96% (n = 1,013)
to 49.81% (n = 1,161) whilst remaining relatively stable in this time period ranging from
64.42% (n = 1,704) to 65.429% (1,485) in the non-midwifery care model. When the pending
results were analysed, a stable rate of 1.10% (n = 18) was observed in the midwifery led
group, whereas a slight uptrend over the years was found in the non-midwifery led cohort
(4.91%, n = 130, to 6.61%, n = 150). Figures 12 and 13 display these trends in the two
models of care.
Figure 12
Trends of GBS Screening Adherence in the Midwifery Led Model of Care (including
screening details)
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Figure 13
Trends of GBS Screening Adherence in the Non-Midwifery Led Model of Care (including
screening details)
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Comparison of Subgroups
In the following, the results of the different subpopulations in relation to GBS screening
adherence are presented. First, the MGP population is examined and GBS adherence rates are
compared among MGP groups across the five hospitals, followed by investigating results of
the subgroups in Hospital 1 and a summary of adherence rates based on the model of care and
setting. The exploration of results among these subgroups was of particular importance as
vast differences became apparent.
MGP Population. All five hospitals provided the MGP model of care. Among these
MGP groups, the GBS adherence rates and screening details were examined and contrasted.
As this is one midwifery led care provider type, it is surprising that the results of screening
adherence varied vastly ranging from 57.28% (n = 3,166) to 96.19% (n = 730). For Hospital
1 with the largest number of women in the MGP model (n = 5,527), the lowest rate of GBS
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screening adherence was discovered (57.28%). This was followed by a similarly low rate of
62.50% (n = 30) in the small population of Hospital 5. A much higher proportion of pregnant
women were tested for GBS colonisation in the MGP group of Hospital 3 (80.14%, n = 432).
Among all five MGP groups, Hospital 2 and Hospital 4 ranged the highest with 95.33% (n =
2,288) and 96.19% (n = 730) respectively. These findings are displayed in Figure 14.
Figure 14
Prevalence of Adherence to GBS Screening in all MGP Groups
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GBS Screening among Subgroups of H1. Further analysis was conducted when the
GBS adherence rates were investigated. Among the three subgroups of the midwifery led
model of care (MGP, CMP, and PM) at Hospital 1, an interesting trend emerged. The
adherence rate to screening in the MGP group was found to be remarkably low (57.28%, n =
3,166) indicating that close to one half of the proportion of pregnant women (42.72%, n =
2,361) were not tested for GBS colonisation. However, when the results were compared with
the groups of CMP and PM, they were the highest for the GBS screening adherence. In the
CMP cohort, only 48.51% (n = 489) of women underwent GBS testing with 51.49% (n =
519) receiving no GBS test in their pregnancy. Notably, an even lower rate of adherence was
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identified in the PM population (44.05%, n = 74), which means that more than a half of this
group (55.95%, n = 94/168) missed out on screening for GBS colonisation. Figure 15
illustrates these outcomes.
Figure 15
Prevalence of GBS Screening Adherence amongst Subgroups
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In summary, in the midwifery led models of care GBS screening adherence rates were
the highest in Hospital 4 (96.19%, n = 730) with only 3.81% (n = 29) of women not tested.
Similarly high rates were identified among women of Hospital 2 (95.33%, n = 2,288)
indicating that a small 4.67% (n = 112) group of women did not receive GBS screening.
Whilst 80.14% (n = 432) in Hospital 3 was the third highest GBS screening adherence rate
with 19.86% (n = 107) of women not tested, data revealed a much lower rate for women
cared for in Hospital 5 (62.50%, n = 30) with more than a third of women not receiving the
GBS screen (37.50%, n = 18). Surprisingly, the lowest rate of adherence to GBS screening in
this care model was found in Hospital 1 (57.28%, n = 3,166) indicating that over 40% of this
cohort was not tested (42.72%, n = 2361). In the non-midwifery led population, a high
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90.51% (n = 10,748) of pregnant women in Hospital 1 received GBS screening with 9.49%
(n = 1,127) not tested, whereas corresponding findings did emerge for the population of
Hospital 5 in this model of care (82.61%, n = 19 and 17.39%, n = 4 not tested). For these two
hospitals, the group average was nearly identical (H1 – 73%, H5 – 72.55%). Figure 16
illustrates these outcomes.
Figure 16
Adherence to GBS Screening based on Model of Care and Setting (H1 - H5)
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Adherence to Intrapartum Antibiotic Prophylaxis
This section presents findings of adherence to Intrapartum Antibiotic Prophylaxis (IAP)
when women were found to be colonised with GBS via the antenatal screening test. First,
results for the whole study population are provided, which is followed by a comparison
between the two models of care and all subgroups.
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Whole of Study Population
Among all examined women, 3,907 (21.70%) women had an indication for IAP due to
a GBS positive test result. Investigations of adherence to IAP revealed that 73.68% (n
=2,879) women were provided with IAP. The proportion of women who were not
administered the prophylactic intrapartum antibiotics accounted for 26.32% (n = 1,028).
These results are displayed in Figure 17.
Figure 17
Adherence to IAP in the Whole Study Population

All GBS tested women
n = 17,999

IAP indicated

IAP not indicated

n = 3,907

n = 14,092

(21.71%)

(78.29%)

IAP administered

No IAP administered

n = 2,879

n = 1,028

(73.68%)

(26.32%)

Comparison of Models of Care
When adherence rates to IAP were compared between the two models of care on the
numbers of GBS colonised women in each group MLC n = 1,470, NMLC n = 2,437), the
results revealed a low adherence rate in the MLC group (65.51%, n = 963). This means,
34.49% (n = 507) of women did not receive antibiotic prophylaxis in labour. In contrast, in
the NMLC cohort 78.62% (n = 1,916) of women were given IAP, leaving 21.38% (n = 521)
without antibiotic prophylaxis. Figure 18 presents these results.
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Figure 18
Adherence to IAP in the two Models of Care
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Comparison of Subgroups
In the following, different subpopulation results in relation to adhering to the IAP
protocol are presented, commencing with a comparison of adherence rates among the MGP
groups across the five hospitals followed by a presentation of findings of the subgroups in
Hospital 1.
MGP Population. When adherence rates to IAP were compared among the GBS
colonised women of the MGP population of all five hospitals (n = 1,341), enormous
differences were revealed with all findings below 70%. The GBS positive tested MGP
women in Hospital 1 (n = 698) were administered IAP in 67.33% (n = 470) indicating that
32.66% (n =228) women did not receive it. In comparison, remarkably close results were
revealed for the 428 MGP women with GBS colonisation in Hospital 2, of whom 68.45% (n
= 293) received IAP with 31.55% (n = 135) of women not being treated. In contrast, the
adherence rates for Hospital 3 are much lower with just over half of all GBS positive tested
MGP women (n = 72) receiving IAP (59.72%, n = 43) with similar findings among the 136
women in Hospital 4 who were given IAP in 53.67% (n = 73). This means that nearly half of
the proportion of women were not administered IAP in the MGP groups of Hospital 3 and 4
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(H3 40.28%, n = 29; H4 46.33%, n = 63). The adherence rate for Hospital 5 with seven GBS
positive tested women was extremely low at 28.57% (n = 2) indicating that the majority of
these women missed out on IAP (71.42%, n = 5). These results are presented in Figure 19.
Figure 19
Adherence to IAP amongst MGP Groups
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IAP Adherence Rates among Subgroups of H1. On further examination, the results
of subgroups of the midwifery led model of care in Hospital 1 in relation to adherence to IAP
were compared and revealed varying findings. The highest rate was found in the MGP cohort
with 67.33% (n = 470/698) with 32.66% (n = 228) not covered with antibiotics followed by
63.72%, n = 65) in the group of CMP which included 102 GBS colonised women indicating
that 36.28% (n = 37) of women did not receive prophylactic antibiotics. In stark contrast, in
only half of the group of women tested GBS positive in the PM population (n =19), IAP was
adhered to (52.63%, n = 10) whilst 47.37% (n = 9) were not provided with antibiotic
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prophylaxis. Figure 20 displays the adherence rates among the subgroups where IAP was
indicated by a positive GBS test result.
Figure 20
Adherence to IAP in Subgroups of H1
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With the available data at a population level, it was not possible to obtain information
of adequate IAP administration (right timing and dosages). The reason for the lack of
information is the none-requirement of entering these details of IAP into the maternity
database by the care providers.

Summary
Using descriptive statistics, this chapter examined results in relation to the adherence to
the recommended prevention strategy for early-onset neonatal GBS infection in WA. It
commenced describing the sample, which comprised a total number of 22,417 women of the
non-midwifery and the midwifery led model of care and its subgroups across five hospitals in
metropolitan and regional WA. Maternal demographic characteristics were depicted and then
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compared across the two main target groups including a) women’s age distribution; b)
women’s country of birth, which was grouped into six geographical regions; c) number of
pregnancies, and d) number of previous births.
Following this, the results of the analysis were presented according to the three research
objectives. Firstly, the prevalence of GBS colonisation in the pregnant women of each group
was examined. The findings revealed an overall GBS colonisation rate of 21.7% and no
notable differences were observed between the NMLC and MLC cohorts and subgroups.
Secondly, the prevalence of adhering to antenatal GBS screening was investigated and
revealed a remarkable discrepancy in the adherence rates between the NMLC group (90.5%)
and the MLC group (68.8%). Vast variations were found between the MGP groups of the five
hospitals when the adherence rates were explored: a) H1 = 57.3%; b) H2 = 95.4%; c) H3 =
80.1%; d) H4 = 96.2%; e) H5 = 62.5%. Low rates were discovered among the subgroups with
the MGP cohort presenting the highest adherence rate (57.3%), followed by the CMP group
(48.5%), followed by the PM population (44%). The trends of GBS screening characteristics
over the five years were investigated and showed no remarkable changes in the NMLC cohort
whereas an increase was observed of women who were not tested for GBS colonisation
(21.3% to 36.3%) as well as a decline of negative test results (62% to 49.8%) in the MLC
population.
Thirdly, when the adherence to the IAP protocol was investigated, it showed an overall
adherence rate of 73% in all women under study. Differences emerged between the NMLC
and the MLC groups with adherence rates of 78.6% and 65% respectively with even more
contrasting findings across the MGP groups of the five hospitals ranging from 28.57% to
68.45%. The comparison of the subgroups’ adherence to IAP in Hospital 1 found that MGP
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and CMP had similar rates (67.33% and 63.71% respectively) whereas the rate in the group
of PM was remarkably low with 52.63%.
The next chapter presents a discussion of the results.
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Chapter 5 – Discussion

This chapter provides an interpretation of the study’s key findings. First, a discussion of
maternal demographics is presented. This is followed by an analysis of the prevalence of
Group B Streptococcus (GBS) colonisation, and characteristics of adherence to antenatal
GBS screening and intrapartum antibiotic prophylaxis. The results in the whole population as
well as in the two comparison groups (midwifery led versus non-midwifery led models of
care) and subgroups are discussed against the background of current international knowledge.
The chapter concludes with an examination of strengths and limitations, followed by a
summary of the main points.

Maternal Demographics
Women’s Age
Women’s age at birth has dramatically changed in recent decades worldwide due to a
wide variety of social and cultural factors, with an increase of the maternal mean age of up to
six years (Sobotka, 2017). This is reflected in the current study with a woman’s median age
of 30 years, corresponding with previous research investigating GBS in pregnancy (Furfaro et
al., 2019; Jisuvei et al., 2020; Koppes et al., 2017; Kunze et al., 2015; Picchiassi et al., 2017;
Plainvert et al., 2017). Women at the age of 35 years and older are currently the group with
the fastest growing birth rates (Bellieni, 2016). Before 1975, women’s average childbearing
age ranged between 22 and 25 years worldwide (Sobotka, 2017). The observed increase in
age after 1975 has been attributed to enhanced educational, and career opportunities for
women; thus causing delays in childbirth (Bellieni, 2016). A further reason for this trend
noted in the literature relates to growing uncertainty in the economies of countries, where
employment instabilities as well as changes in values, specifically how people view family
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(Sobotka, 2017) have been identified. Increasing maternal age has become associated with
various complications during pregnancy and birth such as hypertension, gestational diabetes,
pre-eclampsia, prematurity, fetal growth restriction and malformation (Bouzaglou et al.,
2020). Further, maternal age has been found to be positively associated with an increased risk
of stillbirth, where it has similarly been linked to placental dysfunction with advanced
maternal age (>35 years of age) that might lead to pregnancy complications (Lean et al.,
2017). In the current study, the number of women older than 40 years was low, comparable
with research by Clouse et al. (2019) who examined GBS among pregnant women in Iran.
The country of birth of the pregnant women in the current study will be discussed next as
another aspect of demographics.
Country of Birth
Demographic characteristics of pregnant women in relation to country of birth were
congruent with prior research (Furfaro et al., 2019). Approximately half of all pregnant
women in this study were born in Australia, whereas the other proportion represented a
diversity of countries of birth from around the world, consistent with findings of an
Australian study by Furfaro et al. (2019). The present study’s results reflect increasing
multiculturalism in Australia due to overseas migration (Rajadurai, 2018), revealing 169
different countries of birth.
This diversity plays an important part in the context of maternity care, requiring
specific attention when it comes to providing culturally appropriate care in pregnancy to
improve maternal and neonatal health outcomes (Coast et al., 2016). Western Australian
hospitals offer specific training for health professionals to ensure effective service provision
to Aboriginal and Torres Strait Islander women (WA Government, 2020). However, there is a
lack of education related to culturally and linguistically diverse women who are not
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Indigenous. Women with non-Australian backgrounds may struggle to access and navigate
through a new healthcare system, which may in turn impact the quality of their healthcare
experience, in particular in the context of pregnancy and birth (Higginbottom et al., 2016). As
one of these cultural challenges, language differences may lead to critical problems in
communication between women with foreign and Indigenous backgrounds and health care
professionals. Women who are hesitant to articulate their language limitations, might miss
opportunities to ask questions. This could lead to feelings of disempowerment or even
inappropriate treatment if a woman is not able to make informed decisions (Higginbottom et
al., 2019).
Cultural awareness includes socio-economic considerations. The various countries
represented by the women in the current study display economic disparities. Differences exist
between women with a cultural background from developed countries who expect to be
involved in the decision making process compared to women from lower income countries
who are less likely to emphasise their rights in active participation in their birth experience
(Shakibazadeh et al., 2018). Further, it is imperative that health professionals are aware of
other barriers for pregnant women born outside Australia, including perceived stereotyping,
discrimination, and culture shock: with competency guidelines actively addressing these
challenges (Higginbottom et al., 2016). It may be important to provide training opportunities
for health professionals in maternity settings to improve their knowledge and understanding
of culturally diverse and appropriate maternity care to meet specific needs of women with
versatile cultural backgrounds. While some training is available for midwives, more
education is needed to ensure culturally appropriate pregnancy care. Whilst challenges in the
provision of maternity care can result from diverse cultural backgrounds, ethnicity can also
have an impact on pregnancy outcomes with women who are GBS carriers.
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Diversity in Ethnicity
This present study corroborates previous findings in research on GBS colonisation in
pregnancy, which has been conducted amongst ethnically diverse women in Australia
(Furfaro et al., 2019) and elsewhere such as Great Britain (Carreras-Abad et al., 2019; GopalRao, Nartey et al., 2017), USA (Edwards et al., 2019; Kum-Nji et al., 2020; Yahya &
Hathcock, 2020), China (Chen, Wen et al., 2019) and Jordan (Clouse et al., 2019). These
studies have examined ethnically diverse populations including Asian, Aboriginal and/or
Torres Strait Islander, Black, Chinese ethnic subgroups, Hispanic, Indian, Latino, Maori,
Pacific Islander and Caucasian demographics. Empirical evidence has suggested that
ethnicity is related to preterm births for pregnant women who were GBS carriers (Callahan et
al., 2017). Explanations offered indicate that varying microbiota of the vagina amongst
women with different ethnic backgrounds may result in labour commencing prior to 37
weeks gestation (Callahan et al., 2017). For example, for a cohort of Indian women, the risk
of giving birth prematurely was found to be as high as 35% compared to 5.3% women
without GBS colonisation (Ashary et al., 2020). Similarly, African American women have
been found to be more likely to carry GBS than Hispanic women (Edwards et al., 2019),
being at a generally higher risk of composite adverse neonatal health outcomes than
Caucasian women (Parchem et al., 2020). These facts indicate that the maternal geographical
background can be associated with pregnancy complications, unlike gravidity, which was not
found to be specifically relevant in the present study as well as in the international literature
in the context of GBS disease. By contrast, parity was a relevant demographic factor in the
studies of GBS in pregnant women.
Parity
The parity examined in the present study reveals comparable results to previous
international research (Jisuvei et al., 2020; Picchiassi et al., 2017). For example, in the current
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study, the proportion of nulliparous women constituted nearly half of all participants, which
corresponds with both Jisuvei et al. (2020) and Picchiassi et al. (2017). Nulliparity has been
associated with preterm birth in a large Danish study (Koullali et al., 2020), presenting a high
risk for neonatal GBS infection (Ashary et al., 2020). Preterm neonates are at a significantly
increased risk of GBS infection and higher mortality rates when compared with neonates
born at term (Heath & Jardine, 2014). Similarly, a world first study that estimated the global
burden of maternal and neonatal GBS disease found that 3.5 million preterm births were
attributable to GBS (Seale et al., 2017). In the current study, approximately half of the
women may have been at a higher risk of preterm birth due to association with nulliparity, as
per the findings of international research.
Whilst the proportion of primiparous women was high in the current study, women
with two or more previous births comprised the minority, which is consistent with previous
findings in Brazil (Szylit et al., 2020) and in China (Chen, Wen et al., 2019). As a typical
phenomenon of Western countries, there are indications that multiparity has fallen
dramatically in the past several decades (Bellieni, 2016). This decline in the number of births
can be explained by variations in socioeconomic factors related to a woman’s country of
residence (Muniro et al., 2019), as well as factors related to career planning, increased
education attainment, travel and financial security. All of these contributing factors are highly
encouraged in contemporary society and have been proposed as reasons for the falling rates
of multiparity in high income countries (Bellieni, 2016). Conversely, a high prevalence of
multiparity can be attributed to women marrying at a young age, a poor uptake of family
planning methods and lower levels of education in women from low income countries
(Muniro et al., 2019). A discussion follows in relation to GBS colonisation amongst Western
Australian pregnant women.
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Prevalence of GBS Colonisation
The current study has examined GBS colonisation data across five hospitals. The
overall rate of 21.70% was similar to average rates in international research (Edwards et al.,
2019; Jisuvei et al., 2020; Ramesh Babu et al., 2017; Szylit et al., 2020) and consistent with
results of previous Australian studies (Braye et al., 2019; Furfaro et al., 2019; Moorhead et
al., 2019). No studies were located to relate findings of the current study in relation to the
different models of care (non- and midwifery led care). However, differences in GBS
colonisation rates in the present study between the two care models, and also between each
hospital across the large geographical area of Western Australia were observed, mirroring
variations between countries (Kwatra et al., 2016; Shabayek & Spellerberg, 2018). As
discussed above, these findings indicate that variations occurred in different ethnic
populations across the world with the highest GBS colonisation rate amongst African women
and the lowest in the pregnant population of Asia and the Middle East (Gopal Rao et al.,
2019; Shabayek & Spellerberg, 2018). The heterogeneity in GBS colonisation in the current
study raises questions in relation to aetiology.
Aetiologic Considerations
Population differences suggest varying natural immunity of pregnant women to GBS
along with factors such as lifestyle, swab collection methods and laboratory techniques which
can also contribute to different GBS colonisation rates (Ashary et al., 2020; Furfaro et al.,
2019; Lao, 2019). Underlying population differences in the natural immunity of pregnant
women to GBS may explain the different GBS colonisation rates in the current study.
Various factors may affect the maternal immune system including anthropometric measures
and racial background (Lao, 2019). Different immune responses occur in women of high
income countries, compared to women from non-industrialised population groups, over the
course of pregnancy, including pro and anti-inflammatory processes possibly due to
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contrasting immunological demands in pregnancy between these ecologically distinct
population groups (Anderson et al., 2020). Additionally, increased immunological tolerance
may result from repeated infections (such as with parasites), known to disproportionately
affect women who grew up in non-industrialised countries (Hové et al., 2020). Further,
anthropometric indicators such as increased Body Mass Index (BMI) have been associated
with higher GBS colonisation and may negatively impact the maternal immune status (Lao,
2019). Whilst the maternal immune response plays a critical role in avoiding the development
of GBS invasion (Korir et al., 2017), the above factors likely interact with the colonisation of
pathogens, potentially resulting in transmission to the fetus (Lao, 2019).
Sexual behaviours may affect differences in GBS colonisation rates (Furfaro et al.,
2019). Frequent sexual intercourse and the use of sex toys have been found to increase the
risk of GBS colonisation in pregnancy (Cools et al., 2016; Furfaro et al., 2019). Moreover,
sexual hygiene, such as the use of vaginal products in pregnancy including lotion (Chen, Wen
et al., 2019) or frequent vaginal washing (Cools et al., 2016) can significantly increase GBS
colonisation rates, as a result of interfering with the microbiome of the vagina via manual and
chemical irritation (Lewis et al., 2017).
Specific specimen collection methods have been found to positively affect GBS
detection rates. For example, detection rates have been found to be influenced by procedures
involving the collection of a combined rectal-vaginal swab as opposed to either vaginal or
rectal specimens (Di Renzo et al., 2015; Furfaro et al., 2019). A combined rectal-vaginal
specimen collection is recommended for GBS detection in Western Australia (Homer et al.,
2014). Whilst it is fair to assume specimen collection following WA recommendations, it was
not possible to determine whether tests were performed adequately across the population of
this study. It is possible that the variation of GBS colonisation between the five hospitals
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could be partly explained by differences in the quality of specimen collection as well as
processing techniques.
Another explanation for variations in GBS colonisation rates in the current study may
involve inconsistencies in specimen testing methods. The current study could not establish
whether a consistent processing technique was used across the laboratories of the five
hospitals involved. Globally, the culture test method is recognised as the ‘Gold Standard’ for
the identification of GBS in pregnant women with a higher sensitivity when broth enrichment
is used (Ashary et al., 2020). American CDC guidelines refer to the American Society for
Microbiology, who specify that with the use of broth media (liquid media used to grow
bacteria) for incubation of specimens, the sensitivity for detecting GBS increases by
approximately 50% compared to direct agar plating (Filkins et al., 2020). Not all laboratories
apply this enrichment step prior to culturing the specimens, which can significantly impact
results as indicated by Ashary et al, (2020). Accordingly, their research found that the GBS
detection rate was almost twice as high compared to the specimens cultured without using the
broth enrichment process. In this regard, it is important to note that other laboratory
techniques have been found to be more effective in isolating GBS strains than others such as
the Granada agar (selective medium consisting of several chemical components for isolating
and identifying GBS) (Jisuvei et al., 2020) or the use of Lim Broth media (enrichment
medium with colistin and nalidixic acid) (Ali et al., 2020).
In summary, underlying population differences in the natural immunity of pregnant
women in relation to variations in GBS carriage have been identified in the literature.
Additionally, women’s lifestyle factors as well as health care practices such as swab
collection and processing techniques, require attention. Further research may provide a
clearer picture of women's circumstances and contexts along with behaviours that identify

90

risk factors for GBS colonisation. Such findings may assist in the development of specific
screening and prevention protocols for maternal and neonatal GBS disease. The results of the
current study examining the prevalence of adhering to the recommended WA GBS screening
guidelines are discussed below.

Adherence to Antenatal GBS Screening
The current study found that the adherence rate to antenatal GBS screening guidelines
was high in the whole population cohort, which corroborated previous Australian (Braye et
al., 2019; Moorhead et al., 2019) and international findings (Berardi et al., 2017). The
differences of adherence rates between the two models of care, as well as the unexpected
findings of the discrepancies between the Midwifery Group Practice groups when compared
separately for each hospital, were surprising and not comparable to literature due to the lack
thereof. This study’s results corroborate previous findings in that GBS adherence rates
amongst pregnant women in the midwifery led model of care were low (Yamaguchi &
Ohashi, 2018). Further, an examination of the five-year trend in the current study indicated an
increase of women in the midwifery led model of care not being tested for GBS colonisation,
when compared to a stable proportion in the non-midwifery led care group. This increased
lack of testing raises important questions as to possible reasons for this trend. There could be
potential professional determinants, such as midwife knowledge and perspectives, differences
in hospital specific acknowledgement of clinical guidelines, non-standardised educational
material for pregnant women, or factors that include women’s knowledge and perceptions as
well as controversial opinions in regard to prevention strategies to avoid neonatal EOGBSD.
Midwives’ Knowledge and Perspectives
Midwives, as the lead professional care provider in the midwifery led model of care,
play a critical role when it comes to adherence to clinical guidelines (Ozan et al., 2019).
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Amongst midwives in this model of care, autonomous practice and women-centred care are
highly regarded (Sheehy et al., 2019). Midwives are the highest ranked source of information
for pregnant women followed by medical personnel and media (McQuaid et al., 2018). By
providing information, education and counselling, a midwife supports women to make
informed decisions and promotes woman-centred care during pregnancy, birth, and the
postnatal period (Hunter et al., 2017). This is an important consideration when examining
adherence to GBS screening guidelines in pregnancy, because the information the woman
receives from the midwife, can significantly contribute to her decision making for or against
the test. Consequently, a midwife’s knowledge and approach to GBS screening remarkably
affects and guides a woman’s decision. Knowledge about GBS in pregnancy among
midwives can differ, as highlighted by one group of parents that stated that health
professionals did not seem well informed about this topic (McQuaid, Jones et al., 2016).
Considering the low adherence rate to GBS screening in the midwifery led model of care in
the current study, possible specific education of midwives to improve adherence to the
recommended GBS screening guidelines in WA may be an effective intervention. In this
regard, Pangerl and colleagues (2021) in their review of the literature have demonstrated that
implementing educational measures into the clinical practice of health professionals can
result in an increase in antenatal GBS screening rates. The knowledge and perspectives of
midwives in relation to GBS screening guidelines might also be impacted by their
backgrounds.
The midwifery workforce in Western Australia comprises midwives from all around the
world. Midwives possess vastly different backgrounds including variations in midwifery
qualifications, scope of practice, midwife to women ratios, professional autonomy, culture,
and practice differences (Philip et al., 2019). The specific imprint of work experience in the
country of qualification may influence clinical practice in WA. For example, midwives
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trained in the United Kingdom, where antenatal GBS screening is not common practice, may
have different viewpoints as compared to midwives from countries with GBS screening
guidelines such as the USA. Further, the recognition of clinical GBS practice guidelines by
midwives is integral in providing quality care with the aim of best health outcomes for
women and their newborns.
Recognition of Clinical Guidelines
The current study does not provide direct evidence as to differences in how clinical
guidelines have been recognised at each hospital. However, it is possible that adherence to
clinical guidelines may explain discrepancies in adhering to GBS screening guidelines in the
present study. Evidence-based clinical guidelines ensure best practice and optimal quality of
clinical care for maternal and neonatal health; therefore, adherence to these standards is an
essential part in the scope of practice of health professionals (Millington et al., 2020).
Notably, adherence rates to GBS screening guidelines in the MGP cohort in the current study
were lowest at a tertiary hospital, where WA GBS screening guidelines were initiated and
found the highest in the hospital furthest away from metropolitan WA. These findings are
inconsistent with an analysis of adherence to other clinical guidelines in a multi-centre study
(Millington et al., 2020). It is possible that the importance of the recommended WA GBS
screening guidelines was acknowledged and interpreted differently in each hospital, which
may be rooted in the personal commitment of midwives to professional accountability and
ownership (Sherman & Cohn, 2019).
Professional accountability in health care requires compliance with workplace protocols
and ethical standards (Davis, 2017). Differences in practice patterns of health professionals
may be explained by a lack of understanding of workplace protocols and procedures
(Sherman & Cohn, 2019). Further, adherence to clinical protocols may be evaluated more or
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less consistently at various hospitals and possibly with different levels of standards for
accountability, responsibility, and ownership of clinical guidelines, which may be influenced
by the leadership or management of the specific health care facility (Hegarty et al., 2019).
The current study’s adherence rates to GBS screening guidelines dwindled further when
subgroups of the midwifery led care model (MGP, CMP, PM) were examined separately,
indicating that the more the care was detached from hospital environments, the lower the
screening rate. It can be speculated that explanations offered above may have influenced the
findings. In addition to the recognition of clinical guidelines, different educational strategies
informing pregnant women about GBS in pregnancy may influence maternity care.
Educational Strategies during Antenatal Visits
The provision of non-standardised education material and methods across the different
population groups might be another contributing factor to dissimilar screening adherence
rates in the present study. Antenatal care is provided in various settings including hospitals,
outpatient care centres, and at home by midwives and obstetricians using differing
educational strategies to inform pregnant women, aiming for the best maternal and neonatal
health outcomes (Silva et al., 2016). Multiple formats for conveying antenatal education to
pregnant women can be utilised such as explanatory booklets, face to face information, group
information sessions, videos, and health apps (Silva et al., 2016). Admittedly, it can be
challenging for health professionals to communicate the same information in all the different
formats. For example, parents who were affected by GBS infection previously, voiced the
importance of adequate antenatal education in relation to GBS, as they felt it was not
provided to themselves (McQuaid et al., 2016b). In the current multi-centre study, antenatal
care was conducted in multiple ways and settings. While it could not be evidenced from the
data, it is reasonable to assume that different methods were used, resulting in different GBS
screening rates. Therefore, a standardised and regulated antenatal education system,
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providing women with equal opportunities for a well-informed decision may need to be
developed. Further, pregnant women’s knowledge and perceptions are important in relation
to adherence to GBS screening.
Women’s Knowledge and Perceptions
Women’s knowledge and perceptions in relation to GBS screening should be
considered. In contemporary Western culture, women understand pregnancy and childbirth
rather subjectively, incorporating their individual circumstances and unique situations
including level of education, previous childbearing experiences and place of residence (Lee et
al., 2019). Empirical evidence suggests that the knowledge of women concerning GBS in
pregnancy and the associated risk of neonatal infection is generally poor (Alshengeti et al.,
2020; McQuaid et al., 2016a; McQuaid et al., 2016b; Sharpe et al., 2015). Differences in
knowledge between women in their first pregnancy compared to women with previous
pregnancies have been observed (McQuaid et al., 2016a), which may have contributed to
variations in GBS screening adherence in the present study. Furthermore, controversial views
among maternity care professionals may explain the observed differences.
Controversial Opinions and Contrasting Views
The discrepancies in findings of the current study in regard to adhering to
recommended prevention guidelines may be a result of different views amongst health
professionals, reflecting a long ongoing debate about which prevention approach should be
adopted (Rao & Khanna, 2020). Various observational studies have examined and compared
the effectiveness of both prevention strategies, finding a significant reduction of neonatal
EOGBSD when the antenatal screening approach is used (Al Luhidan et al., 2019; Bekker et
al., 2014; Cho et al., 2019; Gopal Rao, Townsend et al., 2017; Ma et al., 2018; Nanduri et al.,
2019; O'Sullivan et al., 2019; Shabayek & Spellerberg, 2018; Wicker et al., 2019).
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Importantly, the discontinuation of antenatal GBS screening was found to be significantly
associated with an increase in rates of neonatal EOGBSD in two independent studies (Al
Luhidan et al., 2019; Gopal Rao et al., 2017a). Further, health care providers adopting the
GBS screening approach have argued that approximately 50% of women whose neonates
developed EOGBSD did not display any risk factors including GBS bacteriuria, neonatal
EOGBSD following previous births, prolonged rupture of membranes, preterm labour or
pyrexia in labour, decreasing the potential effect of the risk based approach (Chen, JenkinsMarsh et al., 2019; Eastwood et al., 2015; Gopal-Rao et al., 2017; Hasperhoven et al., 2020).
This is a significant number of women without risk factors whose neonates developed
EOGBSD, indicating that a large number of neonatal infections could not be prevented using
the risked-based approach. In contrast, results from findings in other studies have shown that
the risk-based approach can be effective in reducing neonatal EOGBSD or keeping these
rates stable (Braye et al., 2019; Chen, Jenkins-Marsh et al., 2019; Darlow et al., 2016;
Håkansson et al., 2017).
Practitioners favouring the antenatal GBS screening approach highlight the high quality
of counselling of women who are GBS colonised, whereby the screening approach allows
adequate time to discuss implications and options for management as opposed to the riskbased approach (Steer et al., 2020). Further, as there are scarcely time constrains when
screening for GBS between 35 and 37 weeks gestation, susceptibility testing in case of a
penicillin allergy can be conducted in women with a positive test result (Steer et al., 2020).
The diagnosis with GBS colonisation may cause dissonance for many women and affect their
whole experience of pregnancy, labour and birth (Sharpe et al., 2015). In this regard,
concerns of women and their partners have included: aspects of the woman’s and neonate’s
health; potential risks, as well as implications of birth plans; the normal concept of birth
within the midwifery led model of care; and even the unease regarding the competence of
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midwives (Sharpe et al., 2015). When women were interviewed about the way the GBS
positive result was communicated, the group of women who were given the information by
the midwife via telephone indicated their worry and fear and stated that these feelings could
have been avoided with the provision of the test result in person (Sharpe et al., 2015). Those
findings suggest that the antenatal screening approach allows sufficient time for discussing
the GBS topic and its implications, which is crucial for women in making an informed
decision. Another factor that invoked controversial debate was limitations regarding universal
culture screening in relation to the intermittent nature of GBS (Stoll et al., 2020).
Some women who tested GBS positive in the third trimester were not colonised with
GBS at the time of birth, indicating that they needlessly received prophylactic antibiotics
(Plainvert et al., 2017). Other women did not receive intrapartum prophylactic antibiotics as a
result of a GBS negative result in pregnancy, whilst antibiotics were required because the
GBS status changed to positive at birth (Virranniemi et al., 2019). To minimise this problem,
the CDC adjusted their recommendations of the time of the screening from 35 – 37 to 36 – 37
weeks and six day’s gestation to avoid a decrease of the predictive value of the test (CDC,
2020b). A further disadvantage of antenatal screening relates to long laboratory processes,
taking approximately 72 hours to yield a result, which may result in GBS colonised women
not having antibiotics administered if preterm labour occurs (Delabaere et al., 2017). In
recent years, international research has examined the development of a more efficient method
for timely detection of GBS, resulting in trialing rapid Polymerase Chain Reaction test
methods, which is hoped to provide a faster alternative (Furfaro et al., 2017).
Finally, another controversy involves the exposure to antibiotics with potential effects
on the neonatal gut microbiome, resulting in adverse long-term outcomes as well as antibiotic
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resistance (Seedat et al., 2019). This topic will be discussed in more detail in the thesis in the
context of antibiotic prophylaxis.
As discussed above, current debate is occurring amongst professionals in the field that
requires further research. In the meantime, maternity care providers may assess the
effectiveness of both prevention strategies, as well as the use of point of care testing such as
the PCR, to identify women with GBS colonisation at onset of labour (Steer et al., 2020).
However, until further empirical evidence is obtained, taking the available knowledge into
account, it is fair to argue that the antenatal GBS screening method for targeting intrapartum
antibiotic use is the more efficient method to prevent neonatal EOGBSD until better
strategies become available.
In summary, various possible explanations for the discrepancies of GBS screening
adherence in the current study have been offered. These include midwives’ knowledge and
perspectives, differences in hospital specific recognition of clinical guidelines, nonstandardised antenatal educational material, women’s knowledge and perceptions, as well as
controversial opinions amongst health professionals in relation to EOGBSD prevention
strategies. As previously mentioned, adherence to intrapartum antibiotic prophylaxis is an
integral part of the current study’s findings.

Adherence to Intrapartum Antibiotic Prophylaxis (IAP)
Across the entire population of the current study, close to three quarters of women were
administered IAP where it was indicated by a positive GBS screening result, which is
comparable to previous research (Braye et al., 2019; Gopal-Rao, Nartey et al., 2017;
Moorhead et al., 2019). The discrepancies in adherence rates to IAP guidelines between the
two models of care, MGP groups at each hospital, and subgroups, were again not able to be
related to contemporary literature due to lack of existing studies. However, these findings
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reflect variations in international studies with relatively high adherence rates (Braye et al.,
2019; Gopal-Rao, Nartey et al., 2017; Kunze et al., 2015; Moorhead et al., 2019) and opposed
findings of low rates (Chen, Jenkins-Marsh et al., 2019; Yamaguchi & Ohashi, 2018). Whilst
adherence rates in the current study were higher in the non-midwifery led model of care when
compared to the midwifery led model of care, remarkably low rates were identified in the
groups of the Community Midwife Program and Private Midwives, and the lowest in a
Midwifery Group Practice cohort of one regional hospital. This finding is consistent with
research undertaken in the midwifery led model of care by Yamaguchi and Ohashi (2018).
Whereas these results cannot show contextual influences, possible reasons for this may
include missed opportunities (Geethanath, 2018), knowledge gaps, and, as discussed above,
controversial views among midwives in the midwifery led model of care. Further, concerns
regarding overuse of antibiotics and their possible adverse effects on the neonatal
microbiome are contemporary issues that are discussed below.
The Question of Overusing Antibiotics and its Adverse Effects
Health professionals continue to argue that antibiotics should be used wisely,
particularly in the light of the growing concern of antibiotic resistance globally (Laws et al.,
2019). In the context of invasive neonatal GBS infection, intrapartum antibiotic
administration has been shown to reduce this risk by approximately 80% when combined
with the antenatal screening approach (Morgan et al., 2020). Against this background, health
professionals need to balance the risks of women receiving prophylactic antibiotics with the
GBS screening strategy, compared to a risk-based approach of refraining from the provision
of antibiotics, to determine which approach should be implemented. In this regard, a wide
range of evidence should be considered, such as the meta-analysis by Hasperhoven et al.
(2020), who found no association between using the screening approach and an increased use
of antibiotics.
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The literature has reported a clear risk of adverse effects including alterations to the
fetal microbiome and antimicrobial resistance following antibiotic exposure (Seedat et al.,
2017; 2019). However, consideration should be given to evidence suggesting that whilst
antibiotic use can decrease the count of healthy Bifidobacterium in the microbiome of the
neonate within the first seven days of life, this count normalises at four weeks (Corvaglia et
al., 2016). Furthermore, long-term effects, such as increased BMI in early childhood, were
not found to be associated with the use of GBS specific antibiotic prophylaxis (Metz et al.,
2020). Another concern is the adverse effect of antibiotic resistance (Seedat et al., 2017).
With intravenous penicillin as the first line of antibiotics followed by cefazolin and
vancomycin (in cases of adverse reactions to penicillin) to prevent neonatal EOGBSD
(Morgan et al., 2020), reports of microbial resistance particularly to the latter two antibiotic
types have been documented (Hayes et al., 2020; Moroi et al., 2019; Seki et al., 2015). Whilst
penicillin-resistant GBS have been detected in Japanese patients’ respiratory isolates, they
were not isolated in maternal or neonatal GBS strains (Seki et al., 2015). Until now, GBS is
susceptible to penicillin (Slotved & Hoffmann, 2020); however, it cannot be predicted if and
when GBS develops resistance to penicillin, highlighting the importance of microbiological
stewardship (Hayes et al., 2020). To date, information about adverse effects following
intrapartum GBS prophylaxis appears conflicted. Further research is required to examine the
different positions and investigate effects in longitudinal studies.

Strengths
To the knowledge of the authors, this multi-centre study has been the first to evaluate
GBS screening adherence rates between the midwifery and the non-midwifery led model of
care worldwide, as well as the first research investigating GBS colonisation, screening and
antibiotic prophylaxis adherence in metropolitan and regional Western Australia. Covering
five years, this research included various population groups of pregnant women at different
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risk levels in the metropolitan and regional area across WA and therefore is generalisable to
similar study cohorts. The large size of the sample in relation to all births across WA over the
five years contributes to the applicability of the study.

Limitations
Several limitations should be noted. Firstly, the rates of EOGBSD were not examined
as this would exceed the capacity of this Master of Philosophy. That is also why the analysis
was limited to descriptive statistics. However, to establish current EOGBSD rates specific to
WA and to examine the relationship between specific demographic characteristics and GBS
colonisation, further research should be conducted. Secondly, women with preterm births
(<37 weeks gestation) were excluded because antenatal GBS screening is performed later in
the last trimester of pregnancy. Nonetheless, investigating GBS adherence rates among this
population group might complete the picture of WA rates, as the possibility exists that the
preterm birth occurred after screening was conducted (between 35 and 37 weeks gestation).
Thirdly, due to the lack of information it could not be established whether the GBS swab
collection and laboratory techniques were performed adequately across all maternity settings
under study, which could have been a contributing factor to variations of GBS colonisation
rates between the study cohorts.

Summary
This chapter provided a discussion of the current study’s findings against the
background of contemporary national and international knowledge. It explored demographic
characteristics of the sample and examined the GBS colonisation status among the involved
population groups across the different cohorts. The adherence to the recommended WA GBS
screening guidelines have been interpreted, revealing vast discrepancies between the
midwifery led and the non-midwifery led model of care. This included the subgroups,
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elaborating on midwives’ knowledge and perspectives, differences in hospital specific
recognition of clinical guidelines, non-standardised antenatal educational material, women’s
knowledge and perceptions, and controversial opinions among health professionals as
possible reasons. Lastly, the discrepant results of the adherence to intrapartum antibiotic
prophylaxis between the population groups has been discussed, indicating the concern of
overusing antibiotics, which may result in alterations of the neonatal microbiome and
antibiotic resistance. The study’s strengths and limitations have both been stated. The next
chapter concludes this thesis by providing a summary of the study and recommendations,
which may assist in optimising clinical guidelines and practice to further improve maternal
and neonatal health outcomes.
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Chapter 6 – Conclusion and Recommendations

This chapter summarises the study, provides concluding remarks and is followed by
recommendations. The chapter commences with an outline of the research aim, objectives
and question this study sought to answer. Following this, it provides a brief overview of each
chapter that summarises the steps of the research design, the findings and discussion. The
recommendations may assist in using the obtained knowledge for improving adherence to
clinical GBS screening guidelines in Western Australia and optimising strategies to further
prevent neonatal EOGBSD.

Research Aim, Objectives and Question
This study has aimed to investigate the adherence to the recommended Western
Australian clinical practice guidelines for the prevention of invasive neonatal GBS infection
amongst pregnant women within two different models of care. The following objectives
guided the research:
1.

Determination of the overall and population specific rates of GBS colonisation in
pregnancy in the midwifery led model of care group, the non-midwifery led model
of care group and subgroups including Midwifery Group Practice, the Community
Midwifery Program, and the group of Private Midwives.

2.

Investigation of the overall prevalence of antenatal GBS screening adherence, as
well as specifically to the two main models of care and subgroups.

3.

Examination of the adherence to intrapartum antibiotic prophylaxis in all groups
under study when it was indicated by a positive antenatal GBS screening result.
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The research question this study endeavoured to answer was: What is the prevalence of
adherence to the GBS screening protocol amongst pregnant women of the midwifery led
model of care and the non-midwifery led model of care in a multi-centre study setting in
Western Australia? Various important findings emerged from this research project,
demonstrating that the aim of this study was achieved and that the research question was
answered. The following section provides a research summary of each chapter of this thesis.

Research Summary
Chapter 1 introduced the research topic. This included outlining Group B Streptococcus
colonisation in pregnancy, the risk of neonatal infection, preventative strategies and an
overview of various models of maternity care. A problem statement was offered in relation to
the non-existence of research of the prevalence of adhering to the recommended GBS
screening guidelines in neither model of care in Western Australia. The significance of the
study was outlined, indicating the contribution to contemporary knowledge with an
anticipation of assisting in optimising policies and clinical care to positively impact maternal
and neonatal health outcomes. The aims, objectives and research question were provided.
Chapter 2 presented a narrative review of the available literature investigating
characteristics of adherence to GBS screening guidelines, using a structured approach. The
literature review displayed vast differences in GBS screening and intrapartum antibiotic
prophylaxis adherence rates in global settings, offering possible explanations such as baseline
adherences to GBS protocols, geographical variations in GBS colonisation, and
characteristics of diverse maternity care providers. In Australia, limited studies have been
identified, where none were located within WA. Only one international study examined this
topic among pregnant women of the midwifery led model of care, revealing remarkably low
rates of adherence. The cited studies also highlighted an ongoing debate between the two
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prevention strategies, whilst confirming the superior efficiency of the antenatal screening
approach in preventing EOGBSD when compared to the risk-based approach. The studies
raised concerns in relation to adverse effects due to the overuse of antibiotics yet with limited
evidence available on severe adverse outcomes.
Chapter 3 outlined the methodological framework and methods used to achieve this
study’s aim and objectives and to answer the research question. The chapter explained the
utilisation of a non-experimental quantitative descriptive research design using data provided
by the Department of Health for the timeframe of 2015 – 2019. Ethical considerations
included multi-centre ethics approval obtained from the WA Health Lead Human Research
Ethics Committee via the centralised Research Governance Service and from Edith Cowan
University. Governance approval, site authorisation and data custodian permission were also
acquired.
Electronic data originating from the WA maternity database Stork were received. The
study sample included pregnant women of the midwifery and non-midwifery led model of
care whose pregnancy resulted in a live birth at term (>37 weeks gestation) across five
hospitals in metropolitan and regional WA. Following an extensive data cleaning and
preparation process, a new database was created. New variables were developed to identify
the two main study cohorts and subgroups. Data were explored and analysed in relation to
maternal demographic characteristics, GBS colonisation status, and to adherence rates to
antenatal GBS screening and intrapartum antibiotic prophylaxis.
Chapter 4 presented the study’s results. A demographic comparison yielded comparable
findings of maternal age, gravidity and parity, whereas differences were found in the
geographical backgrounds of women of the two models of care. The rate of GBS colonisation
was similar when compared between the two models of care, with slight variations between
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subgroups. Findings of GBS screening adherence were relatively high in the whole study
population with remarkable discrepancies when the two models of care were compared. The
adherence rate in the midwifery led model of care was much lower when compared to the
non-midwifery led model of care. Further, adherence rates to GBS screening were compared
between the MGP cohorts of each hospital, revealing surprisingly discrepant findings. On
further analysis, GBS screening rates were compared between the subgroups of Hospital 1.
The investigation of adhering to the intrapartum antibiotic prophylaxis protocol indicated
notable differences.
Chapter 5 discussed the interpretation of the results against the background of the
current knowledge. The study uncovered remarkable differences in GBS screening rates and
adherence to policy within WA. This indicates new research and thus new information.
However, results were in line with overall findings of prior international research amongst
population groups of pregnant women, revealing various adherence rates. The chapter
concluded by discussing the strengths and limitations of this study.

Concluding Remarks
This study found that adherence to the recommended clinical practice guidelines in WA
to prevent invasive neonatal GBS infection is lower amongst pregnant women cared for
within the midwifery led model of care when compared to pregnant women in the nonmidwifery led model of care. This also includes the adherence to the protocol of
administering intrapartum antibiotic prophylaxis when indicated by a positive GBS screening
result. Thus, it may be proposed that the midwifery led model of care may reflect differing
knowledge and perspectives of midwives which may impact on the adherence to GBS
screening and management guidelines. Further, it may appear that the concern of
medicalisation of birth – in particular in the low risk pregnancy population – is an influencing
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factor in this regard. Additionally, it seems that pregnant women lack knowledge in relation
to implications of GBS colonisation in pregnancy, which may be a result of non-standardised
antenatal education across maternity care providers in WA. Further conclusions can be drawn
regarding growing concerns of antibiotic overuse and possibly resulting adverse effects
impacting GBS screening adherence. Furthermore, specific GBS screening and management
protocols may be recognised differently in their importance between maternity hospitals and
are evaluated to a greater or lesser extent.
This research project makes a significant contribution to the body of knowledge in
several ways. Firstly, this study has presented a structured investigation of characteristics of
GBS screening adherence plus intrapartum management with antibiotics in two major target
groups of pregnant women in WA. To the researcher’s knowledge, no study has examined the
comparison between the midwifery led and the non-midwifery led model of care in this
context. Findings may inform clinical protocols, as well as the planning and delivery of
clinical care to reduce the risk of neonatal EOGBSD. Secondly, evidence about adherence to
antenatal GBS screening and intrapartum antibiotic prophylaxis emerging from the current
research adds to the limited literature specific to the Australian context. Thirdly, this project
represented a cross-centre research, including various maternity care providers such as
hospital midwives, MGP midwives, community midwives and private midwives in a variety
of metropolitan and regional settings in WA. Further, it involved a population based sample,
leading to findings being generalisable to similar population groups. Finally, the results may
contribute to further research in the context of GBS in pregnancy by providing vital baseline
statistics that do not currently exist. The study may further be used as a basis for replication
research.
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Recommendations
In the following section, a set of recommendations is presented that may provide
opportunities for improved service delivery and research as identified by this study.
Recommendation 1 – Culturally and Linguistically Diverse Women
Pregnant women from culturally and linguistically diverse backgrounds may benefit
from midwives’ knowledge about culturally appropriate and sensitive intervention. Enhanced
knowledge and understanding may positively impact their interaction and decision making
process with pregnant women. Targeted professional development for midwives to raise
awareness about the impact of barriers rooted in foreign backgrounds on individual health
care planning in pregnancy may lead to increased understanding of GBS and an optimised
health care experience for women.
Recommendation 2 – Educational Interventions Specific to GBS in Pregnancy
It is recommended that multifaceted educational interventions that are aimed at
improving adherence to GBS screening guidelines and clinical practice for midwives are
implemented. These may include regular handover meetings, on-line learning modules,
workshops or webinars targeted at optimising specific knowledge in relation to GBS in
pregnancy and strengthening communication skills for obtaining an informed consent for
routine antenatal GBS screening. Regular evaluation of adherence to GBS screening
guidelines in maternity care settings could be the follow-up strategy to maintain improved
adherence levels.
Recommendation 3 – Standardised Antenatal GBS Education
It is recommended that antenatal education in relation to GBS in pregnancy be
standardised for all maternity care providers across WA. Standardised educational material
has the advantage of offering a coherent and complete set of information to every pregnant
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woman and may include the provision of equal sources of information such as pamphlets,
posters, and face to face sessions. Standardised antenatal GBS education will ensure that
pregnant women receive the same information for making an informed decision in relation to
antenatal GBS screening for the prevention of neonatal infection. This strategy could inform
clinical practice guidelines across Western Australian maternity care providers to ensure
effective implementation.
Recommendation 4 – The Need for Further Research
Further qualitative research should seek to explore GBS in pregnancy by examining
women’s, midwives’ and other health professionals’ perspectives and experiences, giving
them further focus and enunciation. Factors affecting adherence to current GBS screening
guidelines amongst pregnant women and midwives in diverse maternity care settings may
provide valuable insight. Qualitative studies are imperative to examine possible reasons why
adherence rates are low in the midwifery led model of care.
Further research should examine risk factors for GBS colonisation including underlying
population differences in maternal natural immunity and lifestyle factors. These findings may
lead to developing targeted GBS screening protocols specific to these risk factors to prevent
neonatal GBS infection. Given GBS colonisation has been identified as a risk factor for
preterm birth, women affected by this should also be the focus of further research attention.
Investigation is warranted on the impact of the ethnic diversity of pregnant women with GBS
on preterm births to find ethnicity specific strategies for the prevention of neonatal GBS
infection.
Further research may examine the use of the intrapartum GBS Polymerase Chain
Reaction (PCR) in WA as a point of care test to detect GBS colonisation in pregnant women
close to labour. GBS PCR testing is being trialled in some hospitals in the Eastern States of
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Australia and internationally. Additionally, research should assist in developing a maternal
vaccination strategy for reducing the GBS disease burden and supplementing intrapartum
antibiotic prophylaxis.
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Appendix C: Syntax of Data Preparation
REFERENCE: Sabine_JA20200520
REQUESTOR: Sabine Pangerl (HDR Student)
PURPOSE: The Stork extracts (Excel) that Sabine received from HSS at WA Health had embedded split cells
for some variables (AN_Care_Provider and AN_Care_Team) that made it impossible to import into a statistical
package for analysis. HSS wouldn't resupply the extracts in a useable format (aka without split cells), so J Alan
reshaped the data on a best endeavour basis, as described here. Additionally, the identification of midwifery
involvement (and further disaggregation into Midwifery Group Program and Community Midwifery Program)
was scattered across multiple variables, so J Alan developed new summary variables, as described here.
COMMENTS:
(1) The Stork extract used here represents a subset of WA hospital sites from
2015 to 2019 and excludes premature births.
(2) Sabine merged the separate Excel extracts from HSS to produce the Excel file
that J Alan imported in Step 1. Before Step 1 in SAS, J Alan saved the Excel
file to CSV format so that the data could be modified and resaved to Excel prior
to importing it into SAS - these modifications involved autopopulating blanks
for those variables (where this could be done robustly) and to ensure each row
contained a unique Study ID. There is no syntax to record this part of
of the job because J Alan used Excel's graphical user interface (GUI).
(3) HSS's creation of rows with split cells was troublesome and time-consuming to fix.
That HSS has so far taken three attempts to supply the extracts has also wasted
time.
(4) J Alan couldn't fully automate this SAS syntax (import and export to Excel)
because ECU IT isn't currently licensed for all of the SAS product files.
SYNTAX AUTHOR: J Alan
SYNTAX CREATE DATE: 20/05/2020
SYNTAX LAST UPDATE: 29/06/2020 (J Alan)
;
**************************************************************************************/
/**************************************************************************************
SYNTAX UPDATES:
29/06/2020 (JA): Fixed the data entry errors in 12 recrods from Northam and Bunbury (Sabine
confirmed with HSS that they were wrong). Also created the new variables:
x_mgp_any, x_cmp_any, x_pm_any, x_other_any. Re-ran x_midwife_any.
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24/06/2020 (JA): Sabine hadn't added all variables when she merged the separate raw Excel files
into a single file. eg, MCG_AS_AN_CARE_TEAM
I restarted from the beginning ... imported each of raw Excel files into a single
Excel file, modified this Excel file (as a csv), converted it back to Excel,
imported it to SAS, modified the SAS syntax below and ran it.
29/05/2020 (JA): Added variables recoding for Birth_Place_Type, AN_Care_Provider and
AN_Care_Team. Created X_Midwife_Any. Problem: Sabine's logic for
distinguishing between the subgroups didn't work because it assumed
the recategorisations were mutually exclusive (they weren't).
Possible options:
(1) rank the values so that one trumps others
(2) recategorise the values to incorporate the lack of mutual exclusivity
(3) create more than one variable that caters for the overlap and keeps the detail.
08/06/2020 (JA): Fixed previous problem using option 3 above.
**************************************************************************************/
/**************************************************************************************
STEP 1: Create permanent library
***************************************************************************************/
libname sabine "C:\Users\jalan\Desktop\Sabine";
/**************************************************************************************
STEP 2: Import Excel file to SAS.
This syntax to import the xlsx data isn't working because my SAS installation is missing
the product file called SAS/ACCESS to PC Files. Waiting for ECU IT to confirm if I can
have it. In the meantime, import the data manually using the GUI in SAS EG.
****************************************************************************************
proc import out = work.temp1
datafile = "C:\Users\jalan\Desktop\Sabine\foo.xlsx"
dbms = excel replace;
getnames = yes;
run;
*/
/**************************************************************************************
STEP 3: Create a file sequencing variable to show the sort order of the data as it
arrived in the Excel datset created by Sabine.
I have assumed the data is sorted so that all rows of data related to the same birth for
the same woman are arranged consecutively. Sabine has confirmed this assumption. This is

151

why we need a unique studyid for each birth from HSS ... to avoid assumptions
***************************************************************************************/
data temp1;
retain x_fileseq; /*Order as the first variable in the view*/
set sabine.modified_by_Janine_20200624;
x_fileseq + 1;
run;
/**************************************************************************************
STEP 4: Recode Registration_Site to shorten it.
***************************************************************************************/
data temp2;
set temp1;
attrib
x_site

label = "Abbreviated version of resgistration_site" length = $ 9;

if registration_site in:("Armadale") then x_site = "AKMH"; /*Must use colon after the in so you don't
need to type in the full hospital name*/
else if registration_site in: ("Broome") then x_site = "BDH";
else if registration_site in: ("Bunbury") then x_site = "BRH";
else if registration_site in: ("King") then x_site = "KEMH";
else if registration_site in: ("Northam") then x_site = "NRH";
else if registration_site in: ("") then x_site = "XXX"; /*Just in case*/
run;
/*Check there are no missing values for the new sequencing variable*/
/*Outcome: All good*/
proc freq data = temp2;
table x_site / missing;
run;
/**************************************************************************************
STEP 5: Create a sequencing variable that consecutively numbers each row of data that we
believe are related to the same birth.
***************************************************************************************/
proc sort data = temp2;
by pregnancy_id x_fileseq;
run;
data sabine.long_births_&sysdate.(drop = x_lag_pregnancy_id);
retain x_fileseq pregnancy_id x_study_seq calendar_year registration_site x_site;
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set temp2;
by pregnancy_id;
retain x_study_seq;
x_lag_pregnancy_id = lag(pregnancy_id); /*Temp variable to get the next part of the syntax to
work properly*/
if first.pregnancy_id then x_study_seq = 1; /*For the first row of data associated with each birth,
number it 1*/
else if pregnancy_id eq x_lag_pregnancy_id then x_study_seq + 1; /*If there are additional rows of
data associated with the same birth, increment the sequence by 1*/
run;
proc sort data = sabine.long_births_&sysdate.;
by x_fileseq x_study_seq;
run;
/*Check there are no missing values for the new sequencing variable*/
/*Outcome: All good*/
proc freq data = sabine.long_births_&sysdate.;
tables x_study_seq / missing;
run;
/**************************************************************************************
STEP 6: Export the long file to Excel.
Same problem as importing, so use EG GUI until ECU IT says I can have the required
SAS product file that will let me automate this step with code.
***************************************************************************************/
/**************************************************************************************
STEP 7: Reshape data from a long to a wide file format.
Create two separate wide files, one for the AN_Care_Provider and another
for the AN_Care_Team. Then join/merge them together and add the other birth variables.
End result is a file where all of the information for EACH birth is contained on a
single row of data.
***************************************************************************************/
proc sort data = sabine.long_births_&sysdate.;
by pregnancy_id x_study_seq;
run;
/*Part i: Wide AN_Care_Provider*/
proc transpose data = sabine.long_births_&sysdate. out = wide1a (drop=_name_ _label_) prefix =
an_care_provider;
by pregnancy_id;
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var an_care_provider;
run;
/*Part ii: Wide_AN_Care_Team*/
proc transpose data = sabine.long_births_&sysdate. out = wide1b (drop=_name_ _label_) prefix =
an_care_team;
by pregnancy_id;
var an_care_team;
run;
/*Part iii: One-to-one merge to combine the variables in each wide file into a single file*/
proc sort data = wide1a;
by pregnancy_id;
run;
proc sort data = wide1b;
by pregnancy_id;
run;
data wide1ab_join;
merge wide1a wide1b;
by pregnancy_id;
run;
/*Part iv: Attach the other variables.
AN_Care_Provider and AN_Care_Team are not included in this part of syntax, because these
were contained in split cells in the original Excel files from HSS, which we have now
fixed in earlier part of STEP 7 and will rejoin to this current data set*/
data wide2 (keep = pregnancy_id x_study_seq calendar_year registration_site x_site mgp_as_an_care_team,
birth_place_type mother_country_of_birth gravida parity total_pregnancies total_livebirths
maternal_age_at_dob receiving_antenatal_care group_b_strep_an_test group_b_strep_test_result
antibiotics_in_labour period_membranes_ruptured

onset_of_labour birth_method_type

c_section_classification birth_gestational_age x_site);
/*Arrange variables in the preferred order*/
retain pregnancy_id x_study_seq calendar_year registration_site x_site birth_place_type
mother_country_of_birth gravida parity total_pregnancies total_livebirths
maternal_age_at_dob receiving_antenatal_care mgp_as_an_care_team
group_b_strep_an_test group_b_strep_test_result antibiotics_in_labour, period_membranes_ruptured
onset_of_labour birth_method_type c_section_classification birth_gestational_age;
set sabine.long_births_&sysdate.;
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/*Effectively reduces the long file to a wide file for the other variables that we want
to keep*/
where x_study_seq eq 1;
run;
/*Part v: Attach the transposed AN_Care_Provider and AN_Care_Team*/
proc sort data = wide2;
by pregnancy_id;
run;
proc sort data = wide1ab_join;
by pregnancy_id;
run;
data wide3;
merge wide2 wide1ab_join;
by pregnancy_id;
run;
/**************************************************************************************
STEP 8: Recode Birth_Place_Type using logic supplied by Sabine
***************************************************************************************/
data wide4;
set wide3;
attrib
x_Birth_place_type_rc1
length = $ 25

label = "Sabine's recode of Birth_place_type - group level"

x_Birth_place_type_rc2
length = $ 25

label = "Sabine's recode of Birth_place_type - subgroup level"

;
/*Recode 1*/
if birth_place_type in: ("Hospital") then x_Birth_place_type_rc1 = "Non-midwifery led care";
else if birth_place_type eq "Born Before Arrival" then x_Birth_place_type_rc1 = "Not
applicable";
else if birth_place_type in: ("CMp","Perth CMP","MGP", "Family Birth Centre") then
x_Birth_place_type_rc1 = "Midwifery-led care";

/*Recode 2*/
if birth_place_type in: ("Hospital") then x_Birth_place_type_rc2 = "Non-midwifery led care";
else if birth_place_type eq "Born Before Arrival" then x_Birth_place_type_rc2 = "Not
applicable";
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else if birth_place_type in: ("CMp","Perth CMP") then x_Birth_place_type_rc2 =
"Community Midwife Groups";
else if birth_place_type in: ("MGP", "Family Birth Centre") then x_Birth_place_type_rc2 =
"MGP Groups";
run;
/*Check there are no missing values for the new recoded variable*/
/*Outcome: All good*/
proc freq data = wide4;
table x_Birth_place_type_rc1 x_Birth_place_type_rc2/ missing;
run;
/**************************************************************************************
STEP 9: Recode AN_Care_Provider using logic supplied by Sabine
***************************************************************************************/
data wide5;
set wide4;
attrib
x_an_care_provider_all
length = $ 150

label = "Merge of AN_care_provider1 to AN_care_provider5"

x_an_care_provider_rc1
length = $ 100

label = "Sabine's recode of AN_care_provider - group level"

CMP"

x_an_care_provider_cmp label = "Sabine's recode of AN_care_provider - subgroup level for
length = $ 9

MGP"

x_an_care_provider_mgp label = "Sabine's recode of AN_care_provider - subgroup level for
length = $ 9

x_an_care_provider_pm
private midwife" length = $ 20
non-midwife"

label = "Sabine's recode of AN_care_provider - subgroup level for

x_an_care_provider_other label = "Sabine's recode of AN_care_provider - subgroup level for
length = $ 9

;
/*There are multiple relevant columns in the wide file format, so concatenate into a single
column*/
x_an_care_provider_all = catx(" / ",an_care_provider1, an_care_provider2, an_care_provider3,
an_care_provider4, an_care_provider5);
/*Recode 1: Find mention of midwife-related care anywhere in AN_care_provider. This new variable
shows if a midwife
was INVOLVED in the ante-natal care and not necessarily that the midwife LED the care*/
if findw(x_an_care_provider_all,"Maternity Group Practice") gt 0 or
findw(x_an_care_provider_all,"Birth Centre Attached to Hospital") gt 0 or
findw(x_an_care_provider_all,"Midwife") gt 0 then x_an_care_provider_rc1 =
"Midwife involved as antenatal care provider";
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else x_an_care_provider_rc1 = "No known midwifery involvement as an antenatal care
provider";
/*Recode 2: Distinguish Community Midwifery Program, MGP Groups and Private Midwives from
other AN_care_providers by
creating separate variables for each one. Impossible to do this by creating a single variable because
the groups
aren't mutually exclusive*/
if findw(x_an_care_provider_all,"Community Midwife Program") gt 0 then x_an_care_provider_cmp
= "Yes CMP";
else x_an_care_provider_cmp = "No CMP";
if findw(x_an_care_provider_all,"Maternity Group Practice") gt 0 or
findw(x_an_care_provider_all,"Birth Centre Attached to Hospital") gt 0 then
x_an_care_provider_mgp = "Yes MGP";
else x_an_care_provider_mgp = "No MGP";
if findw(x_an_care_provider_all,"Private Midwife") gt 0 then x_an_care_provider_pm = "Yes Private
midwife";
else x_an_care_provider_pm = "No Private Midwife";
if findw(x_an_care_provider_all,"Service") gt 0 or
/*Different approach need to find "hospital" only values, because "hospital" is also
mentioned in "Birth Centre Attached to Hospital"*/
an_care_provider1 eq "Hospital" or an_care_provider2 eq "Hospital" or
an_care_provider3 eq "Hospital" or an_care_provider4 eq "Hospital" or an_care_provider5 eq "Hospital" or
findw(x_an_care_provider_all,"General Practitioner") gt 0 or
findw(x_an_care_provider_all,"GP") gt 0 or
findw(x_an_care_provider_all,"Medical") gt 0 or
findw(x_an_care_provider_all,"Obstetrician") gt 0 or
findw(x_an_care_provider_all,"Derbarl Yerrigan") gt 0 or
findw(x_an_care_provider_all,"MBM") gt 0 or
findw(x_an_care_provider_all,"OPH") gt 0 or
findw(x_an_care_provider_all,"Other Provider") gt 0 or
findw(x_an_care_provider_all,"Remote Nurse") gt 0 or
findw(x_an_care_provider_all,"RFDS") gt 0 then x_an_care_provider_other = "Yes
Other";
else x_an_care_provider_other = "No Other";
run;
/*Check there are no missing values for the new recoded variable*/
/*Outcome: There are ~49 records from KEMH where x_an_care_provider is empty. This includes a small
number of born before arrivals, but otherwise the birth_place_type says the birth occurred at KEMH.
Ask Sabine to investigate. Otherwise, all good for the other variables.*/
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proc freq data = wide5;
table x_an_care_provider_all x_an_care_provider_rc1 x_an_care_provider_cmp
x_an_care_provider_mgp x_an_care_provider_pm / missing;
run;
/*This table shows that identifying midwife involvement yields very different results (with some overlap)
depending
on which variable is used (x_birth_place_type_rc vs x_an_care_provider_rc1).*/
proc tabulate data = wide5 missing;
class x_birth_place_type_rc1 x_an_care_provider_rc1;
table x_birth_place_type_rc1 all, x_an_care_provider_rc1 all;
run;
/**************************************************************************************
STEP 10: Recode AN_Care_team using logic supplied by Sabine
***************************************************************************************/
data wide6;
set wide5;
attrib
x_an_care_team_all
length = $ 150

label = "Merge of AN_care_team1 to AN_care_team5"

x_an_care_team_rc1
length = $ 100

label = "Sabine's recode of AN_care_team - group level"

x_an_care_team_cmp
length = $ 9

label = "Sabine's recode of AN_care_team - subgroup level for

CMP"

x_an_care_team_mgp
length = $ 9

label = "Sabine's recode of AN_care_team - subgroup level for

MGP"

midwife"

x_an_care_team_other label = "Sabine's recode of AN_care_team - subgroup level for nonlength = $ 9
;

/*There are multiple relevant columns in the wide file format, so concatenate into a single column*/
x_an_care_team_all = catx(" / ",an_care_team1, an_care_team2, an_care_team3, an_care_team4,
an_care_team5);
/*Recode 1: Find mention of midwife-related care anywhere in AN_care_team. This variables shows if
a midwife
was INVOLVED in the ante-natal care and not necessarily that the midwife LED the care*/
if findw(x_an_care_team_all,"Collie Midwives Clinic") gt 0 or
findw(x_an_care_team_all,"Community Midwife") gt 0 or
findw(x_an_care_team_all,"Green - Maouris - Jade") gt 0 or
findw(x_an_care_team_all,"MANC") gt 0 or
findw(x_an_care_team_all,"Margaret River Midwives Clinic") gt 0 or
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findw(x_an_care_team_all,"MGP") gt 0 or
findw(x_an_care_team_all,"Midwifery Group Practice") gt 0 or
findw(x_an_care_team_all,"Midwifery Led Clinic") gt 0 or
findw(x_an_care_team_all,"Red - Harding - Ruby") gt 0 or
findw(x_an_care_team_all,"Team Midwifery Program") gt 0 or
findw(x_an_care_team_all,"Warren Midwives Clinic") gt 0 or
findw(x_an_care_team_all,"Yellow") gt 0 then x_an_care_team_rc1 = "Midwife
involved in antenatal care team";
else x_an_care_team_rc1 = "No known midwife involvement in antenatal care team";
/*Recode 2: Distinguish Community Midwifery Program and MGP Groups from other AN_care_teams
by
creating separate variables for each one. Impossible to do this by creating a single variable because
the groups
aren't mutually exclusive. Unlike the previous recode, Sabine didn't ask for a variable that flagged
private
midwives (maybe because there were no relevant values???)*/
if findw(x_an_care_team_all,"Community Midwife") gt 0 then x_an_care_team_cmp = "Yes CMP";
else x_an_care_team_cmp = "No CMP";
if findw(x_an_care_team_all,"Collie Midwives Clinic") gt 0 or
findw(x_an_care_team_all,"Green - Maouris - Jade") gt 0 or
findw(x_an_care_team_all,"MANC") gt 0 or
findw(x_an_care_team_all,"Margaret River Midwives Clinic") gt 0 or
findw(x_an_care_team_all,"MGP") gt 0 or
findw(x_an_care_team_all,"Midwifery Group Practice") gt 0 or
findw(x_an_care_team_all,"Midwifery Led Clinic") gt 0 or
findw(x_an_care_team_all,"Red - Harding - Ruby") gt 0 or
findw(x_an_care_team_all,"Team Midwifery Program") gt 0 or
findw(x_an_care_team_all,"Warren Midwives Clinic") gt 0 or
findw(x_an_care_team_all,"Yellow") gt 0 then x_an_care_team_mgp = "Yes MGP";
else x_an_care_team_mgp = "No MGP";
if findw(x_an_care_team_all,"Orange") gt 0 or
findw(x_an_care_team_all,"Antenatal Clinic") gt 0 or
findw(x_an_care_team_all,"Booking Clinic") gt 0 or
findw(x_an_care_team_all,"Midwifery Clinic") gt 0 or
findw(x_an_care_team_all,"Maternity Clinic") gt 0 or
findw(x_an_care_team_all,"NBAC Clinic") gt 0 or
findw(x_an_care_team_all,"Registrar Clinic") gt 0 or
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findw(x_an_care_team_all,"RMO Clinic") gt 0 or
findw(x_an_care_team_all,"Star Clinic") gt 0 or
findw(x_an_care_team_all,"Antenatal Assessment") gt 0 or
findw(x_an_care_team_all,"Antenatal Interview") gt 0 or
findw(x_an_care_team_all,"Booking") gt 0 or
findw(x_an_care_team_all,"Blue") gt 0 or
findw(x_an_care_team_all,"Boodjari Nyarlu Clinic") gt 0 or
findw(x_an_care_team_all,"Boodjari Yorgas Clinic") gt 0 or
findw(x_an_care_team_all,"Boodjari Nyarlu Clinic") gt 0 or
findw(x_an_care_team_all,"Diabetes") gt 0 or
findw(x_an_care_team_all,"DIP") gt 0 or
findw(x_an_care_team_all,"Gold") gt 0 or
findw(x_an_care_team_all,"GP") gt 0 or
findw(x_an_care_team_all,"Green Adolescent - Griffin") gt 0 or
findw(x_an_care_team_all,"Green – Barton – Adolescent") gt 0 or
findw(x_an_care_team_all,"Green – King") gt 0 or
findw(x_an_care_team_all,"Green - Maouris") gt 0 or
findw(x_an_care_team_all,"Green - Das") gt 0 or
findw(x_an_care_team_all,"Green – Maouris – CAMI") gt 0 or
findw(x_an_care_team_all,"Green Team") gt 0 or
findw(x_an_care_team_all,"Next Birth") gt 0 or
findw(x_an_care_team_all,"Obstetric") gt 0 or
findw(x_an_care_team_all,"Obst - led") gt 0 or
findw(x_an_care_team_all,"Red - DAS") gt 0 or
findw(x_an_care_team_all,"Red - Epee") gt 0 or
findw(x_an_care_team_all,"Red - Harding") gt 0 or
findw(x_an_care_team_all,"Red Team") gt 0 or
findw(x_an_care_team_all,"Stork Data Entry") gt 0 or
findw(x_an_care_team_all,"TCTC Clinic") gt 0 then x_an_care_team_other = "Yes
Other";
else x_an_care_team_other = "No Other";
run;
/**************************************************************************************
STEP 11: This step fixes 12 records that Sabine confirmed with HSS contain data entry
errors that fail to detect MGP involvement in the pregancy care.
***************************************************************************************/
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data wide7;
set wide6;
attrib
x_datafix_mgp
length = $ 9;

label = "Fix the Bunbury and Northam records that should mention MGP"

if pregnancy_id in(
/*Bunbury records*/
285549
289330
294766
302042
302059
314873
323909
323988
415641
/*Northam records*/
395345
406680
471403)
then x_datafix_mgp = "Yes MGP";
run;
/**************************************************************************************
STEP 12: Create four new summary variables and save final to a permanent data set.
***************************************************************************************/
data sabine.wide_births_&sysdate.;
set wide7;
attrib
x_mgp_any
items" length = $ 9

label = "Mention of MGP involvement in at least one of six data

x_cmp_any
items" length = $ 9

label = "Mention of CMP involvement in at least one of four data

x_pm_any

label = "Mention of private midwife in at least one data item"

length = $ 20
x_other_any
least one of three data items" length = $ 9

label = "Mention of any non-CMP and non-MGP involvement in at

x_midwife_any label = "Mention of midwife involvement in at least one of five data items"
length = $ 150;
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if x_birth_place_type_rc2 eq "MGP Groups" or
x_an_care_provider_mgp eq "Yes MGP" or
x_an_care_team_mgp eq "Yes MGP" or
findw(mgp_as_an_care_team ,"Midwifery Group Practice") gt 0 or
x_datafix_mgp eq "Yes MGP" then
x_mgp_any = "Yes";
else x_mgp_any = "No";
if x_birth_place_type_rc2 eq "Community Midwife Groups" or
x_an_care_provider_cmp eq "Yes CMP" or
x_an_care_team_cmp eq "Yes CMP" then
x_cmp_any = "Yes";
else x_cmp_any = "No";
if x_an_care_provider_pm eq "Yes Private midwife" then x_pm_any = "Yes";
else x_pm_any = "No";
if x_birth_place_type_rc1 eq "Non-midwifery led care" or
x_an_care_provider_other eq "Yes Other" or
x_an_care_team_other eq "Yes Other" then
x_other_any = "Yes";
else x_other_any = "No";
if x_Birth_place_type_rc1 eq "Midwifery-led care" or
x_an_care_provider_rc1 eq "Midwife involved as antenatal care provider" or
x_an_care_team_rc1 eq "Midwife involved in antenatal care team" or
not missing(mgp_as_an_care_team) or
x_datafix_mgp eq "Yes MGP" then
x_midwife_any = "Yes";
else x_midwife_any = "No";
run;
/*Check there are no missing values for the new recoded variable*/
/*Outcome: All good*/
proc freq data = sabine.wide_births_&sysdate.;
table x_mgp_any x_cmp_any x_pm_any x_other_any x_midwife_any/ missing;
run;
/**************************************************************************************
STEP 13: Export the wide file to Excel. Same problem as importing, so use EG GUI until ECU IT says I can
have the required SAS product file that will let me automate this step with code.
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Appendix D: Age Distribution of all Pregnant Women
under Study (SPSS workings)

GET DATA
/TYPE=XLSX
/FILE='C:\Users\Sabine\Documents\Sabine\Masters\Data analysis\working
data\Final files for analysis\ALL women 1.xlsx'
/SHEET=name 'WIDE_BIRTHS_29JUN20'
/CELLRANGE=FULL
/READNAMES=ON
/DATATYPEMIN PERCENTAGE=95.0
/HIDDEN IGNORE=YES.
EXECUTE.
DATASET NAME $DataSet WINDOW=FRONT.
FREQUENCIES VARIABLES=maternal_age_at_dob
/STATISTICS=STDDEV RANGE MINIMUM MAXIMUM MEAN
/HISTOGRAM
/ORDER=ANALYSIS.
Frequencies
Statistics
maternal_age_at_dob
N

Valid

22417

Missing

0

Mean

30.10

Std. Deviation

5.346

Range

40

Minimum

13

Maximum

53

maternal_age_at_dob
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

13

1

.00

.00

.0

14

14

.06

.06

.1

15

39

.17

.17

.2

16

95

.42

.42

.7

17

174

.78

.78

1.4

18

138

.62

.62

2.1

19

216

.96

.96

3.0

20

337

1.50

1.50

4.5

21

423

1.89

1.89

6.4

22

505

2.25

2.25

8.7
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23

652

2.91

2.91

11.6

24

762

3.40

3.40

15.0

25

927

4.14

4.14

19.1

26

1106

4.93

4.93

24.0

27

1360

6.07

6.07

30.1

28

1444

6.44

6.44

36.5

29

1631

7.28

7.28

43.8

30

1684

7.51

7.51

51.3

31

1746

7.79

7.79

59.1

32

1660

7.41

7.41

66.5

33

1591

7.10

7.10

73.6

34

1319

5.88

5.88

79.5

35

1136

5.07

5.07

84.6

36

926

4.13

4.13

88.7

37

773

3.45

3.45

92.2

38

568

2.53

2.53

94.7

39

440

1.96

1.96

96.7

40

313

1.40

1.40

98.1

41

173

.77

.77

98.8

42

111

.50

.50

99.3

43

79

.35

.35

99.7

44

33

.15

.15

99.8

45

20

.09

.09

99.9

46

11

.05

.05

100.0

47

6

.03

.03

100.0

48

2

.01

.01

100.0

51

1

.00

.00

100.0

53

1

.00

.00

100.0

22417

100.0

100.0

Total
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Appendix E: Mothers’ Country of Birth (SPSS workings)

GET DATA
/TYPE=XLSX
/FILE='C:\Users\Sabine\Documents\Sabine\Masters\Data analysis\working
data\Final files for analysis\ALL women Geographic Regions.xlsx'
/SHEET=name 'WIDE_BIRTHS_29JUN20'
/CELLRANGE=FULL
/READNAMES=ON
/DATATYPEMIN PERCENTAGE=95.0
/HIDDEN IGNORE=YES.
EXECUTE.
DATASET NAME $DataSet WINDOW=FRONT.
FREQUENCIES VARIABLES=GlobalRegion
/PIECHART PERCENT
/ORDER=ANALYSIS.
Frequencies
Statistics
GlobalRegion mother_country_
Global Region
N

Valid

of_birth

22417

22417

0

0

Missing
mother_country_of_birth

Frequency
Valid

Percent

Valid

Cumulative

Percent

Percent

Adélie Land (France)

11

.0

.0

.0

Afghanistan

81

.4

.4

.4

Albania

8

.0

.0

.4

Algeria

4

.0

.0

.5

Angola

2

.0

.0

.5

Argentina

23

.1

.1

.6

Armenia

1

.0

.0

.6

At Sea

2

.0

.0

.6

12445

55.5

55.5

56.1

Austria

9

.0

.0

56.1

Bahamas

2

.0

.0

56.2

88

.4

.4

56.5

Belarus

6

.0

.0

56.6

Belgium

11

.0

.0

56.6

Bermuda

1

.0

.0

56.6

41

.2

.2

56.8

Australia

Bangladesh

Bhutan

165

Bosnia-Herzegovina

28

.1

.1

56.9

3

.0

.0

56.9

144

.6

.6

57.6

11

.0

.0

57.6

Bulgaria

6

.0

.0

57.7

Burundi

20

.1

.1

57.8

Cambodia

15

.1

.1

57.8

Cameroon

2

.0

.0

57.8

133

.6

.6

58.4

1

.0

.0

58.4

22

.1

.1

58.5

374

1.7

1.7

60.2

Christmas Island (Australia)

4

.0

.0

60.2

Cocos (Keeling) Islands

3

.0

.0

60.2

Colombia

48

.2

.2

60.4

Comoros

1

.0

.0

60.4

38

.2

.2

60.6

Cook Islands

4

.0

.0

60.6

COTE DIVOIRE

1

.0

.0

60.6

19

.1

.1

60.7

Cuba

4

.0

.0

60.7

Cyprus

1

.0

.0

60.7

Czech Republic

26

.1

.1

60.9

Denmark

13

.1

.1

60.9

Dominican Republic

2

.0

.0

60.9

East Timor

6

.0

.0

61.0

Egypt

18

.1

.1

61.0

El Salvador

21

.1

.1

61.1

580

2.6

2.6

63.7

Eritrea

26

.1

.1

63.8

Estonia

16

.1

.1

63.9

Ethiopia

85

.4

.4

64.3

Fiji

9

.0

.0

64.3

Finland

8

.0

.0

64.4

France

126

.6

.6

64.9

Gabon

2

.0

.0

64.9

GAZA STRIP AND WEST

3

.0

.0

64.9

150

.7

.7

65.6

Botswana
Brazil
Brunei Darussalam

Canada
Cayman Islands
Chile
CHINA (EXCLUDES SARS +
TAIWAN)

CONGO, DEMOCRATIC
REPUBLIC OF

Croatia

England

BANK
Germany, Federal Republic Of
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Ghana

24

.1

.1

65.7

Greece

11

.0

.0

65.8

Guinea

5

.0

.0

65.8

Honduras

1

.0

.0

65.8

HONG KONG (SAR OF CHINA)

52

.2

.2

66.0

Hungary

21

.1

.1

66.1

Iceland

4

.0

.0

66.1

1152

5.1

5.1

71.3

151

.7

.7

71.9

Iran

72

.3

.3

72.3

Iraq

94

.4

.4

72.7

465

2.1

2.1

74.8

Ireland - Republic Of

8

.0

.0

74.8

Isle Of Man

1

.0

.0

74.8

Israel

19

.1

.1

74.9

Italy

95

.4

.4

75.3

Ivory Coast

3

.0

.0

75.3

Jamaica

3

.0

.0

75.3

Japan

138

.6

.6

76.0

Jordan

15

.1

.1

76.0

Kazakhstan

10

.0

.0

76.1

Kenya

101

.5

.5

76.5

KOREA, DPR (NORTH)

129

.6

.6

77.1

KOREA, REPUBLIC OF

17

.1

.1

77.2

1

.0

.0

77.2

16

.1

.1

77.2

Laos

1

.0

.0

77.2

Latvia

3

.0

.0

77.3

Lebanon

11

.0

.0

77.3

Liberia

32

.1

.1

77.5

Libya

15

.1

.1

77.5

Lithuania

10

.0

.0

77.6

Luxembourg

1

.0

.0

77.6

Macau

2

.0

.0

77.6

MACAU (SAR OF CHINA)

1

.0

.0

77.6

19

.1

.1

77.7

Madagascar

1

.0

.0

77.7

Malawi

6

.0

.0

77.7

Malaysia

262

1.2

1.2

78.9

Maldives

1

.0

.0

78.9

India
Indonesia

Ireland

(SOUTH)
KOSOVO
Kuwait

Macedonia
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Malta

3

.0

.0

78.9

Mauritania

4

.0

.0

78.9

56

.2

.2

79.2

Mexico

9

.0

.0

79.2

Mongolia

8

.0

.0

79.2

Morocco

7

.0

.0

79.3

Mozambique

1

.0

.0

79.3

Myanmar

73

.3

.3

79.6

Namibia

7

.0

.0

79.6

118

.5

.5

80.1

55

.2

.2

80.4

1

.0

.0

80.4

867

3.9

3.9

84.3

Nigeria

54

.2

.2

84.5

Northern Ireland

20

.1

.1

84.6

Norway

11

.0

.0

84.6

Oman

4

.0

.0

84.7

Other North Africa

1

.0

.0

84.7

218

1.0

1.0

85.6

15

.1

.1

85.7

8

.0

.0

85.7

334

1.5

1.5

87.2

Poland

51

.2

.2

87.5

Portugal

13

.1

.1

87.5

Qatar

4

.0

.0

87.5

Réunion

2

.0

.0

87.5

Romania

25

.1

.1

87.7

Russian Federation

71

.3

.3

88.0

Rwanda

3

.0

.0

88.0

Samoa

6

.0

.0

88.0

Samoa, American

3

.0

.0

88.0

55

.2

.2

88.3

Scotland

124

.6

.6

88.8

Senegal

4

.0

.0

88.8

27

.1

.1

89.0

9

.0

.0

89.0

28

.1

.1

89.1

113

.5

.5

89.6

11

.0

.0

89.7

1

.0

.0

89.7

Mauritius

Nepal
Netherlands
New Caledonia
New Zealand

Pakistan
Papua New Guinea
Peru
Philippines

Saudi Arabia

Serbia
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovakia
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Slovenia

4

.0

.0

89.7

Somalia

140

.6

.6

90.3

South Africa

301

1.3

1.3

91.7

2

.0

.0

91.7

23

.1

.1

91.8

Sri Lanka

117

.5

.5

92.3

Sudan

156

.7

.7

93.0

Sweden

22

.1

.1

93.1

Switzerland

35

.2

.2

93.3

Syria

11

.0

.0

93.3

Taiwan (Province Of China)

84

.4

.4

93.7

Tanzania

10

.0

.0

93.7

Thailand

109

.5

.5

94.2

Togo

2

.0

.0

94.2

Tokelau

2

.0

.0

94.2

Tonga

9

.0

.0

94.3

Trinidad And Tobago

3

.0

.0

94.3

Tunisia

2

.0

.0

94.3

Turkey

21

.1

.1

94.4

Uganda

13

.1

.1

94.4

Ukraine

17

.1

.1

94.5

United Arab Emirates

10

.0

.0

94.6

546

2.4

2.4

97.0

1

.0

.0

97.0
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.7

.7

97.7

10

.0

.0

97.8

Uruguay

3

.0

.0

97.8

Uzbekistan

2

.0

.0

97.8

Venezuela

13

.1

.1

97.9

277

1.2

1.2

99.1

26

.1

.1

99.2

West Bank

3

.0

.0

99.2

Yemen

1

.0

.0

99.2

Yugoslavia

7

.0

.0

99.3

53

.2

.2

99.5

114

.5

.5

100.0

22417

100.0

100.0

Southern And East Africa §
Spain

United Kingdom
UNITED KINGDOM AND
IRELAND §
United States Of America
Unknown (Country Of Birth)

Vietnam
Wales

Zambia
Zimbabwe
Total
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Appendix F: Distribution of Pregnancies in the Whole
Study Population (SPSS Workings)

FREQUENCIES VARIABLES=gravida
/HISTOGRAM
/ORDER=ANALYSIS.
Frequencies
Statistics
gravida
N

Valid

22417

Missing

0

gravida
Cumulative
Frequency

Percent

Percent

1

7645

34.10

34.1

2

6530

29.13

63.2

3

3843

17.14

80.4

4

2015

8.99

89.4

5

1045

4.66

94.0

6

615

2.74

96.8

7

323

1.44

98.2

8

159

.71

98.9

9

88

.39

99.3

10

57

.25

99.6

11

37

.17

99.7

12

29

.13

99.9

13

9

.04

99.9

14

12

.05

100.0

15

4

.02

100.0

16

2

.01

100.0

17

1

.00

100.0

18

1

.00

100.0

20

2

.01

100.0

22417

100.0

100.00

Total
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Appendix G: Distribution of Pregnancies in the Two
Models of Care (SPSS Workings)

Midwifery Led Model of Care
FREQUENCIES VARIABLES=gravida
/STATISTICS=MINIMUM MAXIMUM SEMEAN MEAN MEDIAN MODE
/ORDER=ANALYSIS.
Frequencies
Statistics
gravida
N

Valid

10519

Missing

0

Mean

2.24

Std. Error of Mean

.014

Median

2.00

Mode

1

Minimum

1

Maximum

18

gravida
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

1

3863

36.7

36.7

36.7

2

3321

31.6

31.6

68.3

3

1777

16.9

16.9

85.2

4

817

7.8

7.8

93.0

5

378

3.6

3.6

96.5

6

185

1.8

1.8

98.3

7

76

.7

.7

99.0

8

46

.4

.4

99.5

9

22

.2

.2

99.7

10

16

.2

.2

99.8

11

6

.1

.1

99.9

12

6

.1

.1

99.9

13

3

.0

.0

100.0

14

1

.0

.0

100.0

15

1

.0

.0

100.0

18

1

.0

.0

100.0

171

Total

10519

100.0

100.0

Non-Midwifery Led Model of Care
FREQUENCIES VARIABLES=gravida
/STATISTICS=MINIMUM MAXIMUM MEAN MEDIAN MODE
/ORDER=ANALYSIS.
Frequencies
Statistics
gravida
N

Valid
Missing

11898
0

Mean

2.67

Median

2.00

Mode

1

Minimum

1

Maximum

20

gravida
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

1

3782

31.8

31.8

31.8

2

3209

27.0

27.0

58.8

3

2066

17.4

17.4

76.1

4

1198

10.1

10.1

86.2

5

667

5.6

5.6

91.8

6

430

3.6

3.6

95.4

7

247

2.1

2.1

97.5

8

113

.9

.9

98.4

9

66

.6

.6

99.0

10

41

.3

.3

99.3

11

31

.3

.3

99.6

12

23

.2

.2

99.8

13

6

.1

.1

99.8

14

11

.1

.1

99.9

15

3

.0

.0

100.0

16

2

.0

.0

100.0

17

1

.0

.0

100.0

20

2

.0

.0

100.0

11898

100.0

100.0

Total
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Appendix H: Distribution of Previous Births in the Two
Models of Care (SPSS Workings)
Midwifery Led Model of Care

FREQUENCIES VARIABLES=parity
/STATISTICS=MINIMUM MAXIMUM SEMEAN MEAN MEDIAN MODE
/ORDER=ANALYSIS.
Frequencies
Statistics
parity
N

Valid

10519

Missing

0

Mean

.75

Std. Error of Mean

.010

Median

.00

Mode

0

Minimum

0

Maximum

11

parity
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

0

5321

50.6

50.6

50.6

1

3429

32.6

32.6

83.2

2

1223

11.6

11.6

94.8

3

338

3.2

3.2

98.0

4

135

1.3

1.3

99.3

5

40

.4

.4

99.7

6

20

.2

.2

99.9

7

7

.1

.1

99.9

8

3

.0

.0

100.0

9

2

.0

.0

100.0

11

1

.0

.0

100.0

10519

100.0

100.0

Total
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Non-Midwifery Led Model of Care
FREQUENCIES VARIABLES=parity
/STATISTICS=MINIMUM MAXIMUM MEAN MEDIAN MODE
/ORDER=ANALYSIS.
Frequencies
Statistics
parity
N

Valid
Missing

11898
0

Mean

1.04

Median

1.00

Mode

0

Minimum

0

Maximum

12

parity
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

0

5361

45.1

45.1

45.1

1

3450

29.0

29.0

74.1

2

1700

14.3

14.3

88.3

3

731

6.1

6.1

94.5

4

306

2.6

2.6

97.1

5

184

1.5

1.5

98.6

6

88

.7

.7

99.3

7

38

.3

.3

99.7

8

23

.2

.2

99.9

9

7

.1

.1

99.9

10

7

.1

.1

100.0

11

2

.0

.0

100.0

12

1

.0

.0

100.0

11898

100.0

100.0

Total
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Appendix I is not available in this version of the thesis
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